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Abstract 
RNA virus populations are highly diverse. Mutation, recombination and 
reassortment are the major sources of genetic diversity and the resultant rapid 
phenotypic changes in RNA viruses. The most important consequence of the 
diversity in populations of RNA viruses is variations in fitness. Little is known about 
the implications of the nature and extent of genetic diversity within RNA viral 
populations on viral phenotypes. The processes shaping the genetic diversity also are 
poorly defined, e.g. the effects of genetic bottlenecks.  
Dengue viruses (DENVs) are the cause of the most important mosquito-borne 
viral disease of humans (dengue) in terms of morbidity, mortality and economic 
impact. DENV are genetically diverse and segregate into multiple, genetically 
distinct, lineages that arise and disappear on a regular basis. Whether lineage 
turnover is due to stochastic events and/or to selection pressures is not well 
understood. Furthermore, the impact of the regular genetic bottlenecks created by 
cycles of transmission involving mosquitoes has not been thoroughly evaluated.   
This study found that while most members of DENV populations were less fit 
than the population from which they were drawn, lineage replacements were not 
associated with changes in the distribution of fitness within populations of DENV. 
The proportion of members of DENV-1 populations more fit than the population as a 
whole increased after the explosive outbreak of DENV-1 infection in Yangon in 
1998 suggesting that more fit viruses may have selected during the rapid 
transmission accompanying the outbreak.  
Similarly, pyrosequencing failed to reveal any changes in the nature or 
magnitude to the genetic diversity of these DENV-1 populations that would have 
accounted for the lineage replacements. Analysis of the pyrosequencing data 
suggests that this technology may provide significantly different data to conventional 
Sanger sequencing. 
  
 Population Dynamics of RNA viruses iii 
Repeated passage of DENV-1 through population bottlenecks in cultures of 
mosquito and human cells resulted in characteristic changes in the E gene; this was 
not accompanied by a detectable loss in fitness as suggested by Muller’s Ratchet. 
While this study has not produced a definitive explanation for DENV lineage 
replacement observed in areas where transmission of these viruses is hyperendemic, 
it has provided insights into the structure of DENV populations and to the likely 
impact of population bottlenecks that occur in natural cycles of DENV transmission. 
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Chapter 1: INTRODUCTION 
Dengue viruses (DENVs) are the world’s most important mosquito-borne viral 
pathogens for human in terms of morbidity, mortality and economic impact. DENV 
consist four antigenically distinct serotypes (DENV-1-4), which cause a wide 
spectrum of clinical manifestations. It has been estimated that about 3.6 billion of the 
global population and approximately 120 million travellers are at risk of dengue. The 
number of annual dengue cases is 50-100 million, with approximately 24,000 deaths 
in children (Beatty et al., 2011; Guzman et al., 2010; Halstead, 2007; Ooi & Gubler, 
2009; WHO, 2012b; Wilder-Smith & Gubler, 2008). Dengue incidence has increased 
by 30 fold over the last fifty years and the geographic range of the virus and its 
vectors has expanded into new areas (Wilder-Smith, 2012). Although, only nine 
countries experienced dengue epidemics before 1970, the disease is now endemic in 
more than 120 countries in Africa, the Americas, the Eastern Mediterranean, South-
East Asia and the Western Pacific (WHO, 2012b). There is no commercially 
available DENV vaccine or specific antiviral therapies, after more than fifty years of 
research in this field (Wilder-Smith et al., 2010). Moreover, mosquito control 
measures have largely failed to slow the current dengue incidence.  
DENV is a single stranded, positive sense RNA virus belonging to the genus 
Flavivirus (family Flaviviridae) and comprise four antigenically distinct serotypes 
(DENV1-4). Due to the error-prone nature of RNA polymerase, DENV raises 
significant genetic diversity during their replication (Holmes & Burch, 2000). 
Phylogenetic studies with each serotype of DENV showed that they have diverse 
phylogenetic clusters, which consist of multiple distinct lineages (Holmes & Twiddy, 
2003; Weaver & Vasilakis, 2009).  
DENVs cause frequent outbreaks in a region and most outbreaks are associated 
with lineage replacement (A-Nuegoonpipat et al., 2004; Myat Thu et al., 2004). The 
lineage extinction and replacement on a regular basis is the most surprising features 
of DENVs evolutionary dynamics (Holmes & Twiddy, 2003). Sometimes the lineage 
that persists for a number of years at a given location becomes extinct, as an entirely 
new lineage takes over (Zhang et al., 2005). Several studies have documented 
lineage replacement events on a regional scale. For example, DENV-1 in Myanmar 
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in the late 1990s (Thu et al., 2005) in Cambodia in the early 2000s (Duong et al., 
2011) and DENV-1 in Thailand in the mid-1990s (Lambrechts et al., 2012; Zhang et 
al., 2005), DENV-2 in Vietnam in the early 2000s (Ty Hang et al., 2010), DENV-3 
in Sri Lanka in the late 1980s (Messer et al., 2003), and in Thailand in the early 
1990s (Wittke et al., 2002) and DENV-4 in Puerto Rico during the 1980s and 1990s 
(Bennett et al., 2003). Lineage replacement events are also documented on larger 
scales (Rico-Hesse et al., 1997) where DENV-2 lineages from Southeast Asia 
displaced the American DENV-2 lineage in the Americas during the early 1990s.  
Exploring the cause of this has important implications for dengue 
epidemiology and control (Gubler et al., 1978; Gubler et al., 1981; Lambrechts et al., 
2012; Messer et al., 2003; Rico-Hesse et al., 1997; Steel et al., 2010). As DENV 
lineages often differ in their antigenic properties, determining the mechanisms 
underlying lineage turnover also has implications for vaccine design (Lambrechts et 
al., 2012; Wahala et al., 2010). Mechanisms responsible for lineage replacement help 
to develop prediction models for future dengue epidemics (Lambrechts et al., 2012; 
Ty Hang et al., 2010). Despite this potential significance, it is not clear whether the 
event of strain replacement results from random sampling of viral variants due to the 
stochastic nature of DENV transmission during genetic bottlenecks or due to the 
variation in fitness within populations.  
It is possible that DENV lineages that became extinct are due to the inter-host 
population bottleneck created during natural cycles of transmission involving 
mosquitoes. The term population bottleneck refers to a severe decline in the virus 
population during transmission. Bottlenecks may occur when there is much less than 
5-10 µl of saliva expectorated when mosquito feeds (Smith et al., 2005). As repeated 
population bottleneck passages cause a decline in fitness (Chao, 1990; Domingo et 
al., 2005; Duarte et al., 1992; Elena et al., 1996; Elena et al., 2001; Escarmís et al., 
1996; EscarmIs et al., 1999; Escarmis et al., 2008; Yuste et al., 2000; Yuste et al., 
1999) due to the Muller’s ratchet effect (Muller, 1964), the bottleneck during natural 
transmission could be sufficient to drive DENV strains to extinction. However, the 
impact of the regular genetic bottlenecks in DENV created by cycles of transmission 
involving mosquitoes has not been evaluated.  
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1.1 AIMS OF THE PROJECT 
Given the limited knowledge on whether lineage turnover is due to stochastic 
events and/or to selection pressures are responsible for major lineage replacement 
events, the aims of this thesis are: 
 
Aim 1:  To determine an association between variation in the distribution of fitness 
within populations of DENV and lineage replacement. 
 
Aim 2: To determine the relationship between the nature and magnitude of genetic 
diversity within populations of DENV and lineage replacement.   
 
Aim 3: To determine the impact of inter-host population bottlenecks on the fitness of 
DENV. 
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1.2 SIGNIFICANCE AND DEFINITIONS 
The results of this study will provide valuable insights into the likelihood and 
extent of DENV dynamics and how DENV evolves in nature. Understanding 
evolutionary processes, by which DENV can lead to the emergence of new viral 
variants, will help to develop effective countermeasures.  
 
The terms used in this study are defined below.  
Fitness: Fitness is the replicative capability of a virus in a biological 
environment. 
Population bottleneck: Transfer of small number of viruses during 
transmission. 
Adaptation: Adaptation is the evolutionary process whereby a virus becomes 
better able replicate in its environment.  
Population: Heterogeneous mixture of viruses within an individual virus 
strain.  
Lineage/clade: Group of viral strains related by descent from a common 
ancestor. The terms clade and lineage are used interchangeably in this thesis. 
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Chapter 2: LITERATURE REVIEW 
Viruses are the most abundant and diverse component of the natural 
environment (Bratbak et al., 1990; reviewed in Domingo & Holland, 1997; Fuhrman, 
1999; Suttle, 2005). They are host-dependent intracellular parasites that can change 
their phenotype by rapid alteration of their genetic makeup and can adapt to 
parasitize all known groups of organisms (reviewed in Steinhauer & Holland, 1987). 
The genomes of RNA viruses typically are small, ranging from 3Kb to 30Kb, with an 
average size of about 10Kb. A population of RNA viruses in an infected organism 
may contain as many as 10
12
 virions (Boerlijst et al., 1996; Domingo et al., 1998). 
Moreover, RNA viruses have shorter generation times than DNA viruses. The short 
generation times and large population sizes of RNA viruses are responsible for the 
greater genetic diversity in RNA viruses than in DNA viruses (reviewed in Domingo 
& Holland, 1997). Due to their genetic diversity, RNA viruses can evolve rapidly to 
fill new ecological niches (Domingo & Holland, 1994; Holland et al., 1992).  
 
2.1 SOURCES OF GENETIC DIVERSITY IN RNA VIRUSES 
Mutation, homologous and non-homologous recombination and genome 
reassortment are responsible for most genetic variation in RNA viruses (reviewed in 
Domingo and Holland, 1997). The feature, which most commonly distinguishes 
RNA viruses from DNA viruses, is the high mutation rate of RNA genomes (Holland 
et al., 1982). The mutation frequency in RNA genomes has been estimated to be in 
the range of 10
-3
 to 10
-5
 substitution per nucleotide and per round of replication 
(Domingo et al., 1976; Holland et al., 1982), which are 10
5
 to 10
6
 fold greater than 
the mutation rate of DNA genomes. From 0.1 to 10 mutations can be found in the 
progeny of an RNA virus with a 10Kb genome (Drake, 1991; Holland et al., 1982). 
The mutations in RNA genomes are due principally to the error prone nature of RNA 
dependent RNA polymerases (RdRps). The high error rate associated with RdRps is 
due to an absence of 3
/ →5/ exonuclease proofreading –repair activities (reviewed in 
Steinhauer & Holland, 1987). DNA polymerases have 3
/→5/ exonuclease activity, 
which removes mis-incorporated nucleotides from the transcript during the 
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polymerase reaction (Ahlquist, 2002; Echols & Goodman, 1991; Scheuermann et al., 
1983; Steinhauer et al., 1992).  
 
Recombination can be another major source of genetic variation in viruses with 
either segmented or unsegmented genomes (Holland et al., 1982). Evidence of 
recombination was observed first in polioviruses (Hirst, 1988; Ledinko, 1963). Since 
then, recombination has been observed in picornaviruses (Pringle, 1965), 
coronaviruses (reviewed in Lai, 1990), alphaviruses (Weiss & Schlesinger, 1991), 
flaviviruses (Aaskov et al., 2007; Craig et al., 2003; Tolou et al., 2001; Worobey et 
al., 1999), rotaviruses (Suzuki et al., 1998), hantaviruses (Sibold et al., 1999), 
influenza viruses (Pasick et al., 2005; Suarez et al., 2004) and some plant viruses 
such as bromoviruses (Bujarski & Kaesberg, 1986), carmoviruses (Cavanagh & 
Davis, 1988) and alfalfa mosaic viruses (Huisman et al., 1989). Recombination can 
produce new variants of an RNA genome better able to occupy new ecological 
niches or to evade host immunity or chemotherapy (Aaskov et al., 2007; Chao, 1990; 
Craig et al., 2003). Hahn and others (1988) showed that the alphavirus, Western 
Equine Encephalitis (WEE) virus was a recombinant of Sindbis and Eastern Equine 
Encephalitis (EEE) viruses.  
 
Polioviruses undergo intra-serotypic, inter-serotypic and inter-species 
recombination. Intra-serotypic recombination was identified in poliovirus progeny 
during mixed infection with the mutants ho (resistant to the plaque inhibitory effects 
of horse serum) and g/100µ (resistant to the inhibitory effects of 100µg of guanidine 
per milliliter in agar overlay) under conditions of high and approximately equal 
multiplicity of infection in HeLa cell (Ledinko, 1963). Inter-serotypic recombination 
between the serotype 2 and serotype 3 polioviruses resulted in  a genome composed 
of the 5
/
 end of the serotype 3 genome up to nucleotide 4840 and the 3
/ 
end of 
serotype 2 genome from nucleotide 5672 (Minor et al., 1986). Interspecies 
recombination resulted in the emergence of a pathogenic, vaccine-derived, 
polioviruses through the recombination between poliovirus and coxsackie A viruses  
(Jegouic et al., 2009). Although there are numerous reports of recombination 
between RNA viruses, there still is considerable debate about whether recombination 
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occurs in flaviviruses (Rico-Hesse, 2003). Aaskov et al., (2007) identified the first 
recombinant DENV in a population, which included both parental genotypes. A 
recent study with WNV demonstrated that recombination is a rare event where only 
one recombinant genome was identified out of 154 whole genome sequenced. 
Therefore, it is unlikely that recombination contributes in any significant way to 
genetic variation of WNV (Pickett & Lefkowitz, 2009). 
 
The most common mechanism for recombination is believed to be “copy 
choice” where the RdRp jumps from one RNA template to another. During RNA 
synthesis, the RdRp stops temporarily due to pausing signals in the primary RNA 
template (donor strand), thus providing an opportunity for RdRp to interact with the 
acceptor RNA, leading to template switching events and production of recombinant 
products (Copper et al., 1974; Nagy & Simon, 1997). 
 
Another mechanism proposed for recombination is RNA breakage and ligation. 
It involves ribonuclease-mediated RNA scission and ligation (Tsagris et al., 1991) 
and site-specific ribozyme-mediated RNA breakage and ligation (Morl & Schmelzer, 
1990). Breakage-induced template-switching is a mechanism of recombination, in 
which breakage of the template RNA causes replicase pausing (or termination) and 
may promote replicase-driven template switching (Nagy & Simon, 1997).  
 
Although several studies have identified recombination events in RNA viruses, 
how the recombinant virus influence transmission in nature is largely unknown. 
While recombination may remove deleterious mutations and produce viruses with 
greater fitness (Allison et al., 1990; Lai, 1992) it also may reduce the fitness of 
viruses through accumulation of deleterious mutation (Holmes, 2003; Worobey & 
Holmes, 1999). Moreover, recombination can accelerate the emergence of highly fit 
viruses (resistant HIV (human immunodeficiency virus) against antiretroviral 
therapies) through accumulation of mutations, which give rise to resistance to the 
antiviral compound (Vijay et al., 2008).  
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Genome reassortment also may contribute genetic variability to RNA viruses 
with segmented genomes. Reassortment may occur when a single host (human or 
animal) is infected with two different strains of the same virus. New viral particles 
may contain a mixture of genome segments, some coming from one strain and others 
coming from another strain (reviewed in Nelson & Holmes, 2007; reviewed in 
Webster et al., 1992). It is common in RNA viruses such as reoviruses (Tyler et al., 
1986), bunyaviruses (Beaty et al., 1981; Elliott, 1990; Klimas et al., 1981) and 
influenza viruses (reviewed in Webster et al., 1992). Genome reassortment often 
results in major changes in the antigenic composition of a virus and is known as 
antigenic shift (reviewed in Narayan et al., 1977; Nelson & Holmes, 2007). In 
influenza viruses, RNA reassortment may result in new strains of viruses, which the 
immune system is unable to recognize. Reassortant influenza viruses may have 
appeared in humans in 1918 (Spanish flu), 1957 (Asian flu) and 1968 (Hong Kong 
flu) (Kawaoka et al., 1989; Lindstrom et al., 2004; Taubenberger et al., 2005). The 
emergence of “swine flu” (influenza A, H1N1 virus) in 2009 was associated with the 
triple reassortment of Eurasian and American lineages of swine viruses (Garten et 
al., 2009; Smith et al., 2009; Trifonov et al., 2009). 
 
2.2 CONSEQUENCES OF GENETIC DIVERSITY IN RNA VIRUSES 
The most important consequence of genetic diversity in populations of RNA 
viruses is variation in fitness (Duarte et al., 1992; Duarte et al., 1994). Fitness is the 
“level of adaptation through replicative capability of a virus in a biological 
environment” (reviewed in Domingo & Holland, 1997). Kimura (1983) proposed 
that genetic changes resulted in almost identical relative fitness of the new genomes 
because most changes were “selectively neutral”. However, most other authors 
suggested that the genetic changes result in variation in fitness (Duarte et al., 1992; 
Holland et al., 1982).  
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While most mutations are deleterious, the average fitness of the population 
may decline with each generation during population bottleneck. Population 
bottleneck is the smallest size of viral population during transmission, when the 
population size can be ranged from one virus to several million virions (Duarte et al., 
1994; Duffy et al., 2008; Kibota & Lynch, 1996). Muller (1964) suggested that 
when an asexual population is small and mutation rates are high and 
deleterious, a kind of irreversible “ratchet” mechanism would gradually 
decrease the fitness of the population. “Muller's ratchet” is the process by which 
the “genomes of an asexual population accumulate deleterious mutations in an 
irreversible manner” (Muller, 1964). The effect of Muller’s ratchet has been 
demonstrated with RNA bacteriophage, vesicular stomatitis virus (VSV), foot-and-
mouth disease virus (FMDV) and HIV (Chao, 1990; Duarte et al., 1992; Escarmís et 
al., 1996; Yuste et al., 1999). Consecutive plaque-to-plaque transfers of clonal 
population of VSV resulted in fitness losses (Duarte et al., 1992). However, fitness 
decreases or increases may depend on the size of viral populations. Clarke et al., 
(1993) and Novella et al.,  (1995) demonstrated that fitness was gained during 
repeated transfer of large viral populations (10
5
 to 10
6 
PFU at each passage) in cell 
culture. This may have occurred because selection acts during replicative 
competition, causing accumulation of more fit genomes. In contrast, repeated plaque-
to-plaque transfers of viral populations results in genetic bottlenecks because the 
population size is reduced significantly by each plaquing step (Clarke et al., 1993).  
 
Changes in population size of RNA viruses may have significant effects on 
genetic diversity as well as survival potential. Genetic diversity may be reduced 
greatly during bottleneck transmission (Clarke et al., 1993). Genetic bottlenecks may 
occur constantly during natural transmission of viral populations due to drastic 
changes in the environment and their resultant effects on the availability of host 
populations, in which virus can replicate (Domingo et al., 1996). Genetic bottlenecks 
also may occur during natural transmission of virus populations by droplets, 
mosquito bites, injections, blood transfusions, coitus or even invasion of new tissues 
and organs (Clarke et al., 1993; Duffy et al., 2008; Li & Roossinck, 2004). Wolinsky 
et al., (1992) observed genetic bottlenecks during host to host transmission of HIV. 
There was little genetic diversity in HIV populations immediately after transmission 
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to a newly infected individual HIV but the diversity increased with time following 
the infection. Recent studies with hepatitis C virus (HCV) also demonstrated genetic 
bottlenecks during transmission from one host to another. Only one or four viral 
variants established infection successfully, but the diversity increased over the course 
of infection (Bull et al., 2011; Wang et al., 2010). Another study with HCV 
estimated a number of transmitted viral variants establish successful clinical 
infection, which were ranged from 1 to 37. However, the diversity increased in 
chronic phase (Li et al., 2012). Additionally, genetic bottlenecks may occur during 
the transmission of vector-borne viruses because of the small volume of blood 
ingested by the mosquito and the small volume of saliva injected into the vertebrate 
host (Forrester et al., 2012; Weaver & Barrett, 2004). 
 
Although the two populations of VSV of equal fitness were mutated and 
passaged in cell culture, one population would always out compete the other but the 
winner was not always the same population. This is known as the Red Queen 
phenomena (Clarke et al., 1994). Although the two population of VSV were 
competing for many generations, highly advantageous mutations occurred 
stochastically in variants of one of these two populations, leading to sudden 
exclusion of the other. In association with the Red Queen phenomena, long-term 
competition of the two populations of VSV in cell culture resulted in fitness gains in 
both populations because of the stochastic occurrence of advantageous mutations. 
The Red Queen phenomenon is an evolutionary hypothesis taken from the Red 
Queen's comment: “Now, here, you see, it takes all the running you can do, to keep 
in the same place” (Through the Looking-Glass by Lewis Carroll) (Clarke et al., 
1994).  
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The impact of genetic diversity on the phenotype of a population of viruses is 
largely unknown. While genetic diversity of a viral population provides opportunities 
to produce highly fit viruses to survive in complex environments, most mutations 
appear to be deleterious (Chao, 1990; Craig et al., 2003; Duarte et al., 1994). 
However, Furio and others (2005) demonstrated changes in polymerase gene in VSV 
inducing enhanced fidelity, which  reduces viral fitness. Increase mutation rates did 
not result adaption in BHK-21 cells. Recent reports of increased diversity in 
populations of poliovirus associated with increased virulence (Pfeiffer & Kirkegaard, 
2005; Vignuzzi et al., 2006) appear to argue against most mutations being 
deleterious. Pfeiffer & Kirkegaard, (2005) observed that the mutant poliovirus RdRp 
(glycine to serine amino acid changes at the position 64 of the RdRp 3D pol) had 
greater fidelity than the wild type (glycine 64) poliovirus. The increased fidelity in 
the polymerase generated less genetic diversity due to constrain in expansion in 
sequence space and resulted in decreased virulence. They found the less diverse 
poliovirus populations were less pathogenic in mice than wild-type virus. Hence, 
viruses with increased diversity may be more able to replicate in complex 
environments and be more virulent (Neumann et al., 1998; Vignuzzi et al., 2006). 
However, increased virulence, which results in the death of the host, may restrict the 
spread of the virus and ultimately end transmission. Therefore, it is possible that both 
the nature and extent of the genetic diversity in a population of viruses as well as the 
absolute number of members (peak viraemia) all play a part in determining 
phenotype (Brown et al., 2002; Vignuzzi et al., 2006).  
 
On the other hand, there is a limit to the mutation rate of RNA viruses, which 
can tolerate error during replication. This is often called the error threshold, and if 
crossed will lead to extinction (Domingo, 2000; Duffy et al., 2008; Eigen, 2002; Lee 
et al., 1997). This concept has been used for lethal mutagenesis following antiviral 
treatment (Crotty et al., 2000).  
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2.3 QUASISPECIES DYNAMICS OF RNA VIRUSES 
Eigen & Biebricher (1988) proposed the Quasispecies concept to describe the  
diversity and evolution of viral populations as well as to explain the behaviour of 
RNA viruses at various population levels. Quasispecies were defined as a “given 
distribution of macromolecular species with closely related sequences, 
dominated by one or several (degenerate) master copies” (Eigen & Schuster, 
1977).  
 
To describe the population structure of RNA viruses, the following concepts 
have been proposed (i) The mutation rate of RNA viruses is rapid. The virus cannot 
convert to a single (original) sequence. Therefore, selection acts on the viral 
population as a whole rather than single genotype. (ii) The most common sequence is 
the fastest replicating sequence. (iii) Not all highly replicating mutants are highly fit 
(the most common sequence is not necessarily associated with the most fit virus 
population). (iv) Fitness landscape is irregular (Eigen, 1993; Eigen & Biebricher, 
1988).  
 
Quasispecies exist within a host as a genetically heterogeneous mixture of 
variants that differ from a consensus nucleotide sequence (Figure 2.1). The 
consensus sequence may or may not be identical to the dominant or master sequence. 
Quasispecies arise from rapid genomic evolution of RNA viruses. Support for the 
quasispecies concept has come from studies of Qβ RNA bacteriophage and VSV 
where closely related mutants were observed with a stable consensus sequence that 
was maintained throughout a number of passages (Domingo et al., 1978; Steinhauer 
et al., 1989). Quasispecies structure has been claimed to contribute significantly to 
the failure of HCV treatment (Farci et al., 2000), to AIDS disease progression 
(Essajee et al., 2000) and to persistence of virus infections at the cellular and 
population levels (Domingo et al., 1998) because the mutant populations constitute 
huge reservoirs of variants to face any environmental changes.  
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Quasispecies structure can predict the effects of genetic bottlenecks on viral 
fitness. During repeated bottleneck transmission, virus from the mutant spectrum 
transferred to another host may harbor deleterious mutant genomes, similar, but not 
identical, to the consensus, which generate progeny with decreased fitness. This 
mutant population will adapt to the new environment with a high probability of 
producing a fit virus because selection acts on the consensus population and may 
produce relatively high fit progeny (Domingo, 2002). Quasispecies structure also 
provides a virus population with a molecular memory that exists as minority 
components within the quasispecies mutant distribution. The presence of memory 
genomes in a viral quasispecies may accelerate their adaptive response when a 
selective constraint has already been exhibited by a viral population (Domingo et al., 
2001; Ruiz-Jarabo et al., 2000).  In addition, increased mutagenesis results in the 
extinction of the virus population as predicted by quasispecies theory (Crotty et al., 
2000; Holland et al., 1990; Loeb et al., 1999).  
 
However, the quasispecies model is a controversial concept to describe the 
RNA virus evolution because it differs from those formulated in conventional 
population genetics. Moya et al., (2000) claimed that the quasispecies theory ignores 
population genetics theory when describing the evolution of RNA viruses. Jenkins et 
al., (2001) argued that the quasispecies model would be inappropriate for many RNA 
viral populations because neutral space may be too large to allow formation of 
quasispecies. According to Jenkins observations, “the mutation rate should be high 
enough to generate a heterogeneous distribution of mutants but low enough for the 
master sequence(s) to survive within the population over time, and the population 
size should be large enough to enable the viral population to completely explore the 
neutral space surrounding a fitness peak”. In experiments with Qβ RNA 
bacteriophage, mutants differed from the consensus sequence by an average of only 
one to two nucleotides (Domingo et al., 1978), so the neutral space may have been 
small enough to be completely explored by populations of this virus. Jenkins et al., 
(2001) also claimed that their results demonstrated that a stable consensus sequence 
as observed by Steinhauer et al., (1989) was not sufficient to conclude that an RNA 
virus population was at equilibrium and had formed a quasispecies.  
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Holmes & Moya (2002) argued that the quasispecies is a misleading 
description of RNA virus evolution. They analysed the natural population structure 
of RNA viruses according to quasispecies definitions and drew the following 
conclusions. (i) RNA viruses are highly diverse. This does not require the 
quasispecies concept. (ii) There are neutral sites (those nucleotide positions where all 
possible alleles have equal fitness) in viral populations, which allow the number of 
sequences close to maximum fitness to exceed the population size of the virus itself. 
“This would prevent the formation of a quasispecies because the viral population 
could not occupy all the sequence space around the master sequence and would be 
subject to genetic drift, which in turn would prevent the mutational coupling 
necessary for natural selection to act on the entire mutation distribution” as defined 
by the quasispecies concept. (iii) The existing population genetic model can explain 
why the whole population is the unit of selection. If the population size is small, the 
members with the highest fitness may be lost by genetic drift and so not achieve 
ultimate fixation. (iv) There is no evidence that individual variants of lower fitness 
can outcompete those of those of higher fitness by being surrounded by better-
adapted mutants. 
 
2.4 EVOLUTIONARY DYNAMICS OF RNA VIRUSES 
Evolution is a process whereby changes occur in the genetic composition of a 
population over time. As the RNA virus populations are diverse, they exist as a 
collection of variable genomes within an individual host (Figure 2.1). The changes in 
RNA viruses may be regulated by the host’s immune response after infection, which 
exerts a selective pressure on the virus and bottlenecks at transmission, by which 
shapes the diversity of viral populations transmitted to other hosts. Mutation, 
recombination, reassortment and natural selection are the major driving forces of 
evolution in RNA virus populations (reviewed in Grenfell et al., 2004; reviewed in 
Moya et al., 2004). 
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genomes and genomic polymorphisms are represented by lines and symbols, respectively. 
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Natural selection is a process that favours genes that improve the ability of an 
organism to survive and reproduce and may be classified as either a positive or a 
negative selection. Positive (Darwinian) selection implies that one or more members 
of the population are better suited to a given environment, whereas negative (also 
termed purifying) selection eliminates unfit variants. Selection acts to shape genetic 
diversity (Domingo et al., 1999; Domingo et al., 1996; reviewed in Domingo & 
Holland, 1997; Kimura, 1983). The genetic diversity and evolutionary dynamics of 
RNA viruses causing chronic and acute infections may vary due to difference in the 
pattern of transmission and selective pressures in the hosts. 
 
2.5 DYNAMICS OF RNA VIRUS POPULATIONS CAUSING CHRONIC 
INFECTION 
RNA viruses, like HCV and HIV, cause persistent infections in humans, which 
can last years and allow both intra-host and inter-host (human to human) evolution 
(reviewed in Rambaut et al., 2004; Simmonds, 2004). The mechanisms responsible 
for HCV and HIV persistence involve selection pressure by the host immune system 
that results in sequence changes within the hypervariable region  (HPVR) of the 
envelope gene (E) (Edwards et al., 2012; Fafi-Kremer et al., 2010; Farci et al., 2000; 
Forns et al., 1999; Holmes et al., 1992; Larouche et al., 2012; Nowak et al., 1991; 
Prentoe et al., 2011). Acute hepatitis and HIV infection may progress to chronic 
disease by alteration to the host environment, such as the appearance of neutralizing 
antibodies or cytotoxic T lymphocytes. Under the selection constraints of host 
immunity, viral populations may emerge with enhanced ability to persist in the host 
(Farci et al., 2000; Forns et al., 1999; reviewed in Rambaut et al., 2004; Thomson et 
al., 2011). The persistent nature of HIV and HCV infections accelerates their 
evolution (reviewed in Rambaut et al., 2004).  
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In the case of intra-host HIV replication, strong immune selection (Zanotto et 
al., 1999) along with mutation (0.2 errors per genome) and recombination (3 
recombination per round of replication), increases the rate of evolutionary changes 
(Preston et al., 1988; Zhuang et al., 2002). It has been estimated that the total number 
of HIV virions produced per day in a human host is 10.3 X 10
9
.  Infection of new 
cells with HIV virions take place within 24 to 30 hours of their production (Perelson 
et al., 1996). For HCV, it has been estimated that the total number generated per day 
is 10
12 
(Neumann et al., 1998). Due to the rapid kinetics it is likely that at least 10
9
 
variants with single and/or double nucleotide changes daily will be born in each 
individual at multiple times (Guedj et al., 2010). The structure of the phylogenetic 
tree of HIV and HCV evolution shows evolution within the host, which reflects the 
successive production of advantageous mutations (immune escape mutants) and 
extinction of unfavourable lineages. Intra-host evolution may occur due to the 
continuous immune-driven selection and produce selective variants with relatively 
little genetic diversity at any time point (reviewed in Grenfell et al., 2004; reviewed 
in Rambaut et al., 2004).  
 
However, the inter-host evolutionary dynamics of HCV and HIV are relatively 
slow because the time between transmission events is generally months or even years 
(reviewed in Grenfell et al., 2004). During inter-host transmission and, or primary 
infection, the viral population sizes are small and population is relatively 
homogenous. Transmission of the viruses into the new individuals results in 
population bottlenecks, which greatly reduces the degree of genetic diversity 
(reviewed in Grenfell et al., 2004; reviewed in Rambaut et al., 2004). Few studies 
have quantified the number of HCV and HIV variants responsible for successful 
clinical infection (Boutwell et al., 2010; Bull et al., 2011; Fischer et al., 2010; Keele 
et al., 2008; Li et al., 2012; Wang et al., 2010).  For example, few variants (one to 
five) established the HIV infection after immediately transfer into new host (Keele et 
al., 2008). In HCV, one to two variants established the infection during bottleneck 
transmission (Bull et al., 2011). Multiple bottleneck events were also documented 
within hosts. For example, a decline in HCV diversity was observed after 
approximately 100 days post-infection followed by the emergence of a new viral 
population (Bull et al., 2011).   
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During primary infection, the frequency of advantageous mutants (immune 
escape mutant) was low because immune escape mutants might appear at a relatively 
late stage of infection (Goulder et al., 1997). During the heterosexual transmission of 
HIV, the dominant single sequence was transmitted from the infected donor due to 
the extreme genetic bottlenecks. This viral sequence had a shorter V1-V4 length, 
fewer glycans and a greater susceptibility to neutralization of recipient Env 
glycoproteins. Hence, the earliest events of HIV infection are crucial to identify 
genetic vulnerabilities, which can be targeted for an AIDS vaccine (Derdeyn et al., 
2004). 
 
2.6 DYNAMICS OF RNA VIRUS POPULATIONS CAUSING ACUTE 
INFECTION 
Arthropod borne viruses (arboviruses) are dependent on arthropod vectors to 
transmit them from one vertebrate host to the next. Arboviruses comprise a 
taxonomically diverse group with only a few representative families of RNA viruses 
shown in Table 2.1. Most arboviruses cause acute, symptomatic infections in 
vertebrate hosts and chronic, asymptomatic infections in their arthropod vectors. This 
pattern of transmission requires significant plasticity to succeed in a dynamic host 
environment and imposes some very specific constraints on the evolution of these 
viruses. Arboviruses are not subjected to strong immune selection because of the 
acute nature of their infection. Selective pressures upon DENV appear weak and the 
majority of antigenic sites of E protein are located within T or B cell epitopes 
(Twiddy et al., 2002a; Twiddy et al., 2002b). Strong purifying selection (selection 
against most mutations that change amino acid residues) is a characteristic of 
arboviruses (Holmes, 2003; Jenkins et al., 2002), which is represented by the low 
ratio of non-synonymous (dN) to synonymous (dS)substitutions per site (dN /dS <1). 
Phylogenetic studies of arboviruses with non-synonymous changes over time 
demonstrate that purifying selection is the dominant selective force in arbovirus 
evolution (Holmes, 2003; Woelk & Holmes, 2002). Positive selection has also been 
observed but on rare occasions (Holmes, 2003; Twiddy et al., 2002a; Twiddy et al., 
2002b). 
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Table 2.1 RNA viruses causing acute infection. 
Viral 
Genome 
Family Genera Species Vector Disease caused 
RNA Flaviviridae Flavivirus Dengue virus (DENV), Murray Valley 
encephalitis virus (MVEV), Yellow fever virus, 
Japanese encephalitis virus, St. Louis encephalitis 
virus (SLEV), West Nile virus (WNV) 
Mosquito Viral encephalitis, 
Viral hemorrhagic 
fever 
  Louping ill virus, Powassan virus, Tick-borne 
encephalitis virus (TBE) 
Tick (Ixodes 
spp.) 
Viral encephalitis,  
 Togaviridae Alphavirus Chikungunya virus (CHIKV), Eastern equine 
encephalitis virus (EEEV), O’nyong’nyong virus, 
Ross River virus (RRV), Sindbis virus (SINV), 
Semliki Forest virus, Venezuelan equine 
encephalitis virus (VEEV), Western equine 
encephalitis virus (WEEV),  
Mosquito Viral encephalitis, 
arthritis 
 Reoviridae Orbivirus African horse sickness virus, Bluetongue disease 
virus, Epizootic hemorrhagic disease virus 
Ceratopogonida
e (Culicoides 
spp.) 
Viral encephalitis 
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Table 2.1. RNA viruses causing acute infection (continued).  
 
Viral 
Genome 
Family Genera Species Vector Disease caused 
 Reoviridae Coltivirus Colorado tick fever virus Tick Viral hemorrhagic fever 
 Bunyaviridae Uukuvirus Anopheles A, Anopheles B, Bakau, Crimean-
Congo hemorrhagic fever, Kaisodi, Mapputta, 
Nairobi sheep disease, Phlebotomus fever, 
Turlock; 8 unassigned viruses 
Tick Viral encephalitis, viral 
hemorrhagic Fever 
 Nairovirus Crimean–Congo hemorrhagic fever virus Tick Viral hemorrhagic fever 
 Orthobunya
virus 
California encephalitis virus, La Crosse 
encephalitis 
Mosquito Viral encephalitis 
 Phlebovirus Rift Valley fever virus (RVFV) Mosquito 
(Aedes spp., 
Culex spp.) 
Encephalitis, Viral 
hemorrhagic fever 
 Phlebovirus Pappataci fever, Toscana virus Phlebotomus 
spp. 
Fever 
DNA Asfarviridae Asfivirus African swine fever virus Tick Viral encephalitis, Viral 
hemorrhagic fever 
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Although RNA viruses have the ability to change their sequences, the 
consensus sequences of most arboviruses have been found to be highly genetically 
conserved in nature (Ciota & Kramer, 2010; Holmes & Twiddy, 2003; Jenkins et al., 
2002; Weaver et al., 1992). Analysis of nucleotide substitution revealed that the rates 
of evolution of arboviruses are significantly lower compared to single-host RNA 
viruses (Jenkins et al., 2002). This evolutionary stasis is due to the differential 
selective pressures during replication in diverse vertebrate and invertebrate hosts. 
The mutations, either beneficial or neutral for both hosts, become fixed during 
replication and, the mutations, which are deleterious are purged by purifying 
selection in single host systems (Domingo & Holland, 1997; Holmes, 2003). 
 
2.6.1 The host cycling and costs 
The fitness trade-off hypothesis suggests that this alternation constrains 
arbovirus evolution because of fitness that increases in one host diminishes fitness in 
others. The role of alternate cycles of transmission was first studied with RRV 
(Taylor & Marshall, 1975) where viruses evolved to increased virulence when 
sequentially passaged in mice; however, alternate passage between Ae. aegypti 
mosquitoes and mice constrained changes in virulence. Since then, a number of 
studies have determined how host cycling affects arbovirus evolution (Table 2.2), 
which showing some variations in results between viruses (Coffey et al., 2008; 
Coffey & Vignuzzi, 2011; Cooper & Scott, 2001; Deardorff et al., 2011; Greene et 
al., 2005; Novella et al., 1999; Taylor & Marshall, 1975; Turner & Elena, 2000; 
Vasilakis et al., 2009; Weaver et al., 1999). Although the trade-off hypothesis has 
been addressed in a variety of systems, it remains poorly understand. Alternating 
replication in two divergent hosts (vertebrates and invertebrates) may reduces genetic 
diversity (Ciota & Kramer, 2010). However, there is some conflicting evidence about 
whether the arbovirus host alternation requires trade-offs (Table 2.2). There are also 
some inconsistencies in the literature between virus families (flaviviruses vs. 
alphaviruses) and experimental systems (in vitro vs. in vivo).  
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Table 2.2 Experimental findings for alternate cycles of transmission and evolution of 
arboviruses. 
 
  
Authors Fitness in either cell system Fitness tradeoffs 
(Deardorff et al., 
2011) 
Serial passage of WNV in 
Chickens and mosquitoes results 
increase fitness in same hosts. 
Serial passage of WNV in 
chickens and mosquitoes results 
decrease fitness in different hosts. 
Alternative passage of 
WNV in chickens and 
mosquitoes results increase 
fitness in chickens, 
however, fitness decreased 
in mosquitoes. 
(Coffey & 
Vignuzzi, 2011) 
Serial passage of CHIK in C6/36, 
BHK and HeLa cells increase 
fitness when measured in same 
cells  
Serial passage of CHIK in C6/36, 
BHK and HeLa cells decrease 
fitness when measured in different 
cells 
Alternative passage of 
CHIK in C6/36 and BHK or 
C6/36 and HeLa cells 
increase fitness in both cells  
(Vasilakis et al., 
2009) 
Serial passage of DENV-2 in 
C6/36 and HuH7 cells results 
increase fitness in both cell types 
Serial passage of DENV-2 in 
C6/36 and HuH7 cells results 
decrease fitness in opposite cells 
Most alternating passages 
resulted fitness increase in 
both cell types  
(Coffey et al., 
2008) 
Serial passage of VEEV in 
mosquito and mice hamster results 
increase fitness in both hosts. 
Serial mosquito passage 
significantly reduces viraemia in 
mouse. Serial mouse passage 
significantly reduces infectivity in 
mosquito. 
Alternating passages results 
no detectable fitness 
increase in both host types. 
 
(Greene et al., 
2005) 
Serial passage of SNV in mosquito 
and BHK cells results increase 
fitness in both hosts but fitness 
decreased in bypass cells. 
Most alternating passages 
resulted fitness increase in 
both cell types. 
(Cooper & 
Scott, 2001) 
Serial passage of EEEV in 
mosquito and avian cells results 
increase fitness in both hosts but 
fitness decreased in bypass cells. 
Alternating passages 
resulted fitness increase in 
both cell types in a manner 
similar to that observed for 
single host-adapted viruses. 
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Table 2.2. Experimental findings for alternate cycles of transmission and 
evolution of arboviruses (continued). 
 
  
Authors Fitness in either cell system Fitness tradeoffs 
(Turner & 
Elena, 2000) 
Fitness increase when BHK ells 
adapted VSV passaged serially in 
BHK but fitness fluctuates when 
adapted VSV passaged serially in 
HeLa, MDCK. 
 
Alternating passages between 
HeLa and MDCK resulted 
fitness increase in both cell 
types. 
(Novella et al., 
1999) 
Serial passage of VSV in BHK-
21 and LL-5 cells results increase 
fitness in both cells. 
Alternating passages between 
BHK-21 and LL-5 cells 
resulted fitness increase in 
both cell types. 
(Weaver et al., 
1999) 
Serial passage of EEEV in 
mosquito and BHK cells results 
increase fitness in both hosts but 
fitness decreased in bypass cells. 
Alternating passages resulted 
fitness increase in both cell 
types in a manner similar to 
that observed for single host-
adapted viruses. 
(Smith-Tsurkan 
et al., 2010)  
Serial passage of VSV (five 
replicates) in HeLa, MDCK and 
BHK-21 cells 
One replicate adapted to 
HeLa cells experienced a 
tradeoffs in MDCK and 
BHK-21 cells and second 
replicate experience tradeoffs 
but not in  BHK-21 cells 
(Taylor & 
Marshall, 1975) 
Viruses evolved to increased 
virulence when sequentially 
passed in mice.  
Alternate passage between 
Ae. aegypti mosquitoes and 
mice constrained changes in 
virulence. 
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2.6.2  The flaviviruses 
Flaviviruses have single-stranded, positive sense RNA genomes that are 
approximately 11 kb in length with a single long open reading frame (ORF) (Monath 
& Heinz, 1996). A previous study with DENV-2 demonstrated that serial passages in 
single cells result in a fitness gain but the fitness is lost in the bypass cell line. Most 
alternating passages resulted in fitness increases in both cell types. Fewer genetic 
changes were seen in consensus full length sequences of the C6/36 cell passaged 
viruses relative to the HuH7 cell passaged or alternate passaged viruses (Vasilakis et 
al., 2009). Another study evaluated whether serial passages of DENV-2 resulted in 
changes in diversity in mosquito and mammalian cells (Chen et al., 2003).  Thirty 
sequential passages in Vero cells resulted in four amino acid changes in consensus 
sequence whereas no consensus change occurred with 30 sequential passages in 
Aedes albopictus mosquito (C6/36) cell culture. Viruses passaged in Vero cells 
reached higher titres than mosquito cells. 
 
A recent study with the WNV virus demonstrated that specialized viruses gain 
fitness in vivo in chicks and mosquitoes. However, the alternative passage of WNV 
in chickens and mosquitoes results in increasing fitness in chickens, however, fitness 
decreased in mosquitoes (Deardorff et al., 2011). In vitro serial passage studies with 
WNV and SLEV demonstrated that fitness increased in mosquito cells but fitness 
was lost in chicken cells (Ciota et al., 2007). Serial passage of SLEV in vivo in 
chicks showed increased infectivity in chickens but was unchanged in mosquitoes, 
while mosquito specialized viruses were unchanged in both systems (Ciota et al., 
2009). Taken together, results from in vitro and in vivo flavivirus passage studies do 
not support host cycling resulting in significant fitness trade-offs. 
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2.6.3 The alphaviruses 
Like flaviviruses, the alphaviruses genomes are a single stranded, positive 
sense RNA, approximately 11 kb in length. It has two ORFs. One full-length 
genomic is responsible for the translation of non-structural proteins and one 
truncated subgenomic is responsible for translation of structural genes. Like the 
flavivirus, experimental passage studies with alphaviruses also provide some 
contradictory results on the fitness trade-offs and evolutionary constraints. That 
alternate transmission constrains host-specific adaptation was first demonstrated by 
Taylor and Marshall (1975) where in vivo sequential passage of RRV in mice 
resulted in increased virulence; however, alternate passage between Ae. aegypti 
mosquitoes and mice constrained changes in virulence. However, other studies 
(Coffey & Vignuzzi, 2011; Cooper & Scott, 2001; Greene et al., 2005; Weaver et al., 
1999) argued that host alternation constrains host-specific adaptation (Table 2.2). For 
example, a sequential passage with EEEV in either BHK or C6/36 cells results in 
fitness increases in both cells. Moreover, fitness was also gained when EEEV was 
passaged in alternate cells, which were equivalent to the levels in sequentially passed 
strains. More consensus sequence changes were observed in alternate passaged 
viruses than specialized viruses (Weaver et al., 1999). A subsequent study with 
EEEV passaged alternatively in ecologically appropriate cells in avian samples 
(Peking duck embryo cells) and mosquitoes resulted in adaptation in both cells with 
no substantial cost in terms of viral growth or infectivity. However, genetic change 
was not evaluated in this study (Cooper & Scott, 2001).  
 
Alternate passage with SINV also demonstrated that alternate cycling results in 
fitness increases in both host environments. Although fitness gains in alternately 
passaged strains were less than those measured in sequentially passed strains, some 
cycled strains achieved host-specific gains equivalent to those sequentially passaged. 
Furthermore, consensus genetic changes were less in alternate passaged strains 
relative to specialized strains (Greene et al., 2005). A recent study with CHIKV 
demonstrated that alternate passaging in C6/36 and BHK or C6/36 and HeLa cells 
increases fitness in both cells. Alternate passaged viruses showed higher fitness than 
serially passaged viruses. However, mutation frequency in alternately passaged 
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viruses was less than that for the serially passaged viruses (Coffey & Vignuzzi, 
2011). 
Given these results, both in vitro and in vivo passage studies with alphaviruses 
demonstrate that the rate of evolutionary change is constrained by host cycling but 
host adaptation is attainable without significant fitness trade-offs through cycling.  
 
2.6.4 Genetic diversity of arboviruses 
If an individual is infected with 10
3-5
 MID50/ml of DENV through Aedes 
mosquito bites  (Gubler & Rosen, 1976), which is amplified to 10
7.5-8.5 
MID50/ml in 
human blood (Vaughn et al., 2000), we can expect a 5 X 10
11
 fold amplification of 
input virus. Given an estimated error rate of 10
-3–10-4 nucleotides/genome/round of 
replication (Holland et al., 1982), it is anticipated that a significant proportion of the 
genomes of alpha- and flaviviruses in any human host are likely to be defective. This 
is borne out by the small number of studies that have been undertaken to investigate 
this issue (Aaskov et al., 2006; Wang et al., 2002a). However, no estimates have 
been made of how much genetic diversity arises during replication of these RNA 
viruses in their human and mosquito hosts or of the relative roles of host immunity 
and the accumulation of deleterious mutations in the termination of viraemia. 
Selective pressures in vertebrate and invertebrate systems may play an important role 
on arboviruses diversity. Studies with DENV also showed that the genetic diversity 
is less in the human serum than in infected mosquitoes (Aaskov et al., 2006). Intra-
host genetic diversity of WNV derived from mosquitoes in nature was also found to 
be more diverse than chicken hosts (Jerzak et al., 2005). Arbovirus populations are 
homogenous in vertebrate hosts, which may be due to the strong purifying selection. 
Conversely, populations are more diverse in mosquitoes, which may be due to lack 
of adaptive immune response compared to vertebrates results in relaxed purifying 
selection during replication (Ciota & Kramer, 2010).  
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2.6.5 Effects of genetic changes in arbovirus transmission 
Arbovirus sequence variation has significant implications for transmission 
potential. Despite a slower rate of evolution observed in arboviruses (Jenkins & 
Holmes, 2003), they still have the capacity to produce mutants that can be exploited 
to a new niche. Single substitutions may have profound effects on replicative ability 
or infectivity in particular hosts. For example, emergence of a new serotype of 
DENV is often associated with a large outbreak (Thu et al., 2004). Genotype 
replacement of DENV-2 in Vietnam is associated with increased incidence, which 
was found to have higher replicative capability in human hosts (Ty Hang et al., 
2010). New strains of DENV in Sri-lanka and Thailand appeared more fit in 
mosquitoes (Hanley et al., 2008; Lambrechts et al., 2012). The NY99 genotype of 
WNV was replaced by a new genotype WN02 (Davis et al., 2005), which was found 
to be transmitted earlier and more efficiently by Culex mosquitoes (Moudy et al., 
2007). Taken together these findings indicate that although the evolutionary rates of 
arboviruses are slow, they have the capacity to produce variants that have a higher 
potential for transmission. 
 
2.6.6 Adaptability 
Arboviral diversity facilitates adaptability to new and dynamic environments. A 
single mutation (serine to asparagines) in the E2 glycoprotein gene of VEEV was 
responsible for adaptation in mosquitoes (Brault et al., 2004) and for equine 
virulence (Anishchenko et al., 2006). Similarly, diverse CHIKV populations were 
found to be able to survive under the effects of antiviral compounds, escape 
neutralization by antibodies (Coffey et al., 2011; Coffey & Vignuzzi, 2011) and 
replicate in mice and mosquitoes more efficiently than less diverse populations. The 
outbreaks of CHIKV in the islands of the Indian Ocean were associated with the 
emergence of new strains that shared a single common substitution in the E1 
envelope gene in conjunction with a variable second mutation (Powers et al., 2000; 
Schuffenecker et al., 2006), allowing adaptation to Ae. albopictus mosquitoes (de 
Lamballerie et al., 2008; Tsetsarkin et al., 2007). In cell culture, a single amino acid 
change (Cysteine to Tyrosine at the position 483 of the nsP4 RdRp) in CHIKV 
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resulted in resistance to the ribavirin or fluorouracil (5-FU) mutagen (Coffey et al., 
2011).  
 
2.6.7 Genetic diversity and fitness 
While viral diversity has been shown to facilitate adaptability, the role of 
diversity on fitness is also well defined (Arias et al., 2004; Coffey et al., 2011; 
Martinez et al., 1991; Ruiz-Jarabo et al., 2000; Vignuzzi et al., 2006). Recent studies 
with WNV demonstrated that more diverse populations are more fit in mosquitoes 
(Fitzpatrick et al., 2010). Some studies have identified recombination events in 
flaviviruses (Tolou et al., 2001; Worobey et al., 1999) but the extent to which that 
recombinant viruses contribute to fitness is not yet understood. A defective genome 
also observed in DENV populations, which can be maintained by co-infecting 
functional genomes within the mutant spectrum (Aaskov et al., 2006). Another study 
was carried out with DENV defective interfering (DI) viral particles, where large 
sections of the genome of a parental virus have been deleted and the remaining sub-
genome fragment is replicated by complementation with co-infecting functional 
viruses (Li et al., 2011). Vignuzzi et al., (2006) also found evidence that co-operative 
interactions within poliovirus populations increased their replicative ability. 
However, much of the extensive genetic diversity, e.g. defective genomes and DI 
particles, within DENV population may reduce viral fitness significantly. 
 
There is limited data on the distribution of fitness of viruses within 
populations. Duarte and her colleagues (1994) demonstrated that most viruses within 
a population of VSV are less fit than the fitness of viruses as a whole. There were 
only a few highly fit variants surrounded by less fit variants. Due to the deleterious 
nature of mutation in RNA viruses, the fitness of most individual viruses within the 
population is less than the population as a whole; however, cooperative activity 
within populations helps to maintain their overall fitness. As the transmission of 
arboviruses is different than to that of single host viruses the existence of 
complementation and interactive fitness will increase complexity to measure the role 
of individual viruses on fitness. 
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While some deleterious mutations that arise during viral replication may be 
removed by selective sweeps in the host (Holmes, 2003), some of the newly mutated 
viruses may replicate more efficiently (be fitter) in their vertebrate host than the input 
virus from the mosquito or other arthropod. It is also possible that at times when 
there is an abundance of mosquitoes (see below), there is selection for viruses that 
replicate fastest because they may reach a titre that is sufficient to infect a mosquito 
before more slowly replicating members of the population. However, there have been 
no estimates of changes in the fitness of the component members of arboviral 
populations during periods of high and low transmission. 
 
The fitness of arbovirus populations influences transmission. A number of 
studies have demonstrated how the fitness of arboviruses influences transmission in 
mosquitoes. For example, the DENV-1 lineage in Thailand was replaced due to 
increased transmission potential in mosquitoes (Lambrechts et al., 2012). The 
Southeast Asian genotype of DENV-2 was found to be more susceptible in the Aedes 
mosquito than the American genotype (Armstrong & Rico-Hesse, 2003) resulting in 
displacement of the American genotype (Rico-Hesse et al., 1997). Superior 
infectivity of DENV-3 strains (group B) were found in mosquitoes in the displaced 
DENV-3 (group A) in Sri Lanka (Hanley et al., 2008). The WN02 genotype of WNV 
was found to be transmitted more efficiently in Culex mosquitoes, which displaced 
the circulating genotype NY99 (Moudy et al., 2007). Transmission patterns also 
influence arbovirus fitness. For example, virus transmission during population 
bottlenecks reduces virus fitness through the action of Muller’s ratchet (Muller, 
1964). 
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2.6.8 Population bottlenecks in arboviruses 
A population bottleneck is the reduction of fitness by reducing the genetic 
diversity of the virus population (Duarte et al., 1992). The role of population 
bottlenecks, which shape the arbovirus mutant spectrum, is crucial to understanding 
arbovirus evolution. Both theoretical and experimental studies demonstrate that RNA 
viruses are susceptible to significant loss of fitness from repeated bottlenecks 
(Muller’s ratchet) due to their inherent tendency to produce deleterious variants 
(Bergstrom et al., 1999; Clarke et al., 1993; Escarmis et al., 2006; Novella, 2004). 
Arboviruses may experience frequent genetic bottlenecks due to the nature of 
transmission cycling. Small amounts of blood from vertebrate hosts are taken by 
mosquitoes and small amounts of saliva are transmitted to vertebrate hosts. 
Arboviruses may also face bottlenecks within an individual host, with a small 
number of the population establishing infection and dissemination in multiple tissues 
and cell types that differ in physiological and biochemical properties. Seasonal 
bottlenecks may also occur during the dry season, when mosquito populations 
decrease, and the likelihood of mosquitoes feeding on infected hosts becomes lower. 
However, the size and pattern of these bottlenecks are not well defined and they are 
likely to be highly variable among both host and viral species.  
 
For the arboviruses that use mosquito vectors, bottlenecks may occur upon 
infection in midgut cells, dissemination from the midgut, infection of the salivary 
glands, and subsequently emergence into the salivary secretion during transmission 
to vertebrate hosts (Ciota & Kramer, 2010; Kramer et al., 1981; Smith et al., 2008). 
Within vertebrate hosts, bottlenecks similarly occur with the initial establishment of 
infection in skin, and the subsequent spread through various tissues, especially into 
the blood for transmission back to the vector. However, it remains unclear what 
constitutes a population bottleneck within individual hosts. 
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Although genetic bottlenecks within the mosquito are well documented, the 
details of the extent to which they shape virus evolution are yet to be understood. 
Bottlenecks were observed upon infection, dissemination and transmission of VEEV 
in Culex Taeniopus (Forrester et al., 2012). Infection of Aedes taeniorhynchus 
mosquito with VEEV demonstrated that only a few midgut cells are infected initially 
due to the anatomical bottleneck (Smith et al., 2008). Conversely, a recent report 
failed to demonstrate that significant population bottlenecks occur during intra-host 
transmission of WNV from midgut to the saliva of Cx. Quinquefasciatus mosquitoes, 
suggesting anatomical barriers do not impose genetic bottlenecks (Brackney et al., 
2011). Identical non-consensus WNV genomes have been detected in intra-host 
populations infecting birds, suggesting that population bottlenecks may not be as 
restrictive as had been assumed (Jerzak et al., 2005). 
 
The transmission size and patterns have profound effects on RNA virus 
evolution (Elena et al., 2001). Transmission size is the amount of virus required 
for one host to be able to infect a second. If the transmission size of arboviruses for 
infection in humans and mosquitoes is different, the size of the population bottleneck 
may vary among hosts. No measurement has been made of the amount of mosquito-
derived virus required to infect a human host. Gubler & Rosen (1976) estimated that 
the infectious titer of dengue in Aedes mosquitoes is between 10
3
 and  10
5
 MID50. 
Smith and others (2006) demonstrated that mosquito saliva contain 11 PFU VEEV 
during transmission in vivo in mice. Recent studies with WNV estimated that 
mosquitoes can transmit up to 10
6
 PFU of WNV on live hosts (Styer et al., 2007). 
Depending on hosts and viruses, there are a variable amount of viruses present in 
mosquito saliva but it is not yet clear how much virus is exactly required to cause 
infection in humans.  
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Vaughn and others (2000) estimated that there is as much as 10
7.6-8.5
MID50/ml 
of DENV in the blood of a patient. Although experimental infection of DENV in 
mosquitoes through artificial infectious blood feeding exists in the literature, there is 
no data of how much virus is exactly required to infect mosquitoes by human 
feeding.  
 
The number of mosquitoes available to transmit viruses is extremely dependent 
on environmental factors. This is evident from the huge differences in the number of 
reports of dengue, epidemic polyarthritis (RRV infection) or other arbovirus 
infections in “wet” and “dry” seasons.  In the dry season, there are fewer sites with 
enough water in which mosquitoes can lay eggs, and so mosquito numbers decrease. 
Even in optimal conditions, mosquitoes like Aedes aegypti, which are the urban 
vector of DENV, have a half life as short as 7-8 days (Harrington et al., 2001) that is 
less than the extrinsic incubation time of 12 to 25 days (Gubler et al., 2007; Watts et 
al., 1987). This means that even if the mosquito is infected, it may die before it can 
transmit DENV. Successful maintenance of a genetic bottleneck of DENV indicates 
that even a low number of infected mosquitoes in the dry season may be enough to 
continue transmission. The most significant feature of all the bottlenecks is the 
ability of arboviruses to survive seasonal interruptions in transmission cycles. 
Phylogenetic studies suggest that most arboviruses are maintained in the local 
ecological conditions (Weaver, 2006); however, the mechanism for this seasonal 
maintenance may be variable.  
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2.7 THE EMERGENCE OF DENGUE  
Over the past few decades, dengue has become recognized as the world’s most 
important mosquito-borne viral disease in terms of morbidity, mortality and 
economic impact. The distribution of dengue and its vectors has expanded 
dramatically into new geographic areas over the last 40 years due to increasing 
urbanization, inadequate mosquito control and air travel (Gubler, 1998; Ooi & 
Gubler, 2009; Wilder-Smith & Gubler, 2008). It has been estimated that 3.6 billion 
people of the world’s tropical areas and approximately 120 million travellers are at 
risk of dengue. The projected number of annual dengue cases is 50-100 million, with 
approximately 24,000 deaths, mainly among children (Beatty et al., 2011; Halstead, 
2007; WHO, 2002; Wilder-Smith, 2012). More than 500,000 people with severe 
dengue require hospitalization each year, where a large proportion of individuals are 
children and about 2.5% of those affected die. Only nine countries had experienced 
dengue epidemics before 1970. However, the disease is now endemic in more than 
100 countries in Africa, the Americas, the Eastern Mediterranean, South-east Asia 
and the Western Pacific (WHO, 2012a).  
 
2.8 THE ECONOMIC BURDEN OF DENGUE 
An average hospital stay for an individual dengue patient is 5-10 days. There is 
a substantial economic loss resulting from the cost of hospital care and absence from 
work. The cost in Australia has been estimated to have been AU $41.3 million over 
18 years period, i.e., AU$1291 per patient (Canyon, 2008). Dengue is estimated to 
cost US $2.1 billion every year in the Americas, i.e., US$382 per patient (Shepard et 
al., 2011). Dengue illness in Singapore from 2000 to 2009 was estimated to cost 
between $0.85 to $1.15 billion US dollars (Carrasco et al., 2011). In five countries in 
the Americas (Brazil, El Salvador, Guatemala, Panama, and Venezuela) and three 
countries in Asia (Cambodia, Malaysia, and Thailand) the cost of an ambulatory 
patient was estimated to be I$514 and I$1,394 for a patient in a hospital setting 
(Suaya et al., 2009). The cost of laboratory-confirmed dengue, in 2001, in Thailand 
was estimated to be approximately US$61 for each family, a member of which 
contained a dengue patient and is more than the average monthly income in Thailand 
(Clark et al., 2005).  
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The disability-adjusted life year (DALY) is a measure of overall disease 
burden expressed as the number of years lost due to illness, disability or early death. 
DALYs are calculated by taking the sum of these two components, years of life lost 
and years lived with disability (WHO, 2013). Dengue has been estimated to cause a 
burden of 750,000 DALYs per million populations worldwide annually (Meltzer et 
al., 1998; Murray et al., 2012). An annual average disease burden in Singapore from 
2000 to 2009 was estimated at 9-14 DALYs per 100,000 habitants (Carrasco et al., 
2011). The burden of 2114 dengue cases of children in Thailand 1998 to 2002 was 
estimated at 465.3 DALYs per million populations per year (Anderson et al., 2007). 
The burden of dengue in Thailand was estimated at 427 DALYs per million 
population in 2001 (Clark et al., 2005). Despite this substantial burden of dengue on 
human population, there is currently no available licensed vaccine or antiviral 
therapy (Gubler & Meltzer, 1999; Monath, 1994; Wilder-Smith et al., 2010). 
Moreover, mosquito control strategies such as habitat reduction and spraying 
insecticides to reduce dengue infection are currently ineffective (Gubler, 1998).  
 
2.9 TRANSMISSION VECTORS FOR DENGUE 
Dengue viruses (DENV) are transmitted to healthy humans by infected female 
Aedes mosquitoes or vice versa. Aedes aegypti and Aedes albopictus are highly 
competent, efficient vectors for dengue transmission that persist closely with human 
habitats such as water and domestic/peri-domestic environments (Bancroft, 1906; 
Chandler & Rice, 1923; Gubler, 1998).  
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2.10 DISEASE MANIFESTATIONS  
Once DENV has established an infection in a human, the virus may remain 
between 2 days and 2 weeks in the infected individual. The incubation period of the 
virus is about 5 to 6 days (Simmons, 1931). A primary DENV infection with a single 
serotype induces a life-long protective immunity to the infecting serotypes, which 
also induces a short-term cross protective immunity to the other serotypes (Sabin, 
1952). Clinical manifestations range from asymptomatic sero-conversion to 
haemorrhagic manifestations, capillary leak and hypovolaemia, which are 
characteristic of dengue haemorrhagic fever (DHF) and dengue shock syndrome 
(DSS) (Gubler, 1998; Hammon et al., 1960).  
 
2.11 FACTORS ASSOCIATED WITH DENGUE 
Severity of dengue is influenced by complex interactions between host and 
viral factors. Host genetic factors, such as the CD209 promoter variant, DCSINGN, 
increase the risk of DHF (Despres et al., 2005; Sakuntabhai et al., 2005). Similarly, 
the specific FcgammaRIIa (CD32) contains a polymorphic variant (H/R131) that 
reduces risk for developing DHF (Garcia et al., 2010). The gender of the host 
influences the severity of the disease with females more susceptible for DHF/DSS 
than males (Guerra-Silveira & Abad-Franch, 2013; Rudnick et al., 1965). Obesity in 
an individual will increase the risk of DHF/DSS due to an extensive immune 
response to infection (Pichainarong et al., 2006). Populations with malnutrition are 
less susceptible for DHF/DSS due to weak immune responses to infection (Nguyen 
et al., 2005). Ethnicity also influences dengue severity, as DHF/DSS was observed 
significantly more in whites than blacks in Cuba (Bravo et al., 1987). Blanton and 
others (2008) demonstrated that African or Afro-Brazilian ethnic populations were 
more protected against DHF than Brazilians. The immune response of the host will 
increase the risk that DHF/DSS antibody-dependent enhancement will increase 
DENV infectivity (Halstead & O'Rourke, 1977; Hawkes & Lafferty, 1967). DENV 
infected macrophages induce proinflammatory cytokines (tumour necrosis-α and 
interleukin-6), causing plasma leakage and DSS (Anderson et al., 1997; Halstead & 
O'Rourke, 1977). Secondary infection caused by different serotype of DENV induces 
an excessive immune response that increases the risk of developing DHF/DSS 
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(Halstead, 1988), particularly in children 5-9 years of age (Hammond et al., 2005; 
Rudnick et al., 1965).  
 
Host factors may be important determinants for the variation in the clinical 
manifestations of DENV infection. Few cellular factors that modulate DENV 
infection have been characterized. The difference in susceptibility between human 
and mosquito cells could be the number or quality of viral receptors present in the 
cell surface. The possible DENV receptors in human and mosquito cells described in 
the literature are shown in (Table 2.3). For example, adherent cells (Huh) express 
heparan sulphate, a putative receptor for DENV attachment (Chen et al., 1997; 
Hilgard & Stockert, 2000; Lin et al., 2002). Viral factors also influence the nature 
and severity of dengue. It is possible that, sequence-specific determinants can 
modulate the rate of antigen accumulation or viral packaging or secretion. It has been 
shown that sequence differences in prM, E, NS4B, NS4, 5/ UTR and 3/ UTR of 
DENV-2 were associated with DHF (Leitmeyer et al., 1999). The antigenicity of 
DENV can cause an excessive immune response by interaction of the virus with the 
host immune cells, increasing the risk of DHF/DSS (Halstead et al., 1977). Changes 
in antigenicity can alter vaccine targets, which will lead to ineffective vaccines 
against DENV (Clarke, 1960). Cellular tropism of DENV determines severity. The 
attachment of the envelope (E) protein to target cells can determine the infectivity 
and pathogenesis of DENV (Bielefeldt-Ohmann et al., 2001; Chen et al., 1996). 
DENV co-infecting with other viruses in humans influences severity. HIV patients 
infected with DENV did not develop prolonged DENV viraemia (Mendes et al., 
2006; Wang et al., 2006). Dengue serotypes also play an important role in severity. 
DENV-2 was more likely to cause DHF than other serotypes (Halsey et al., 2012; 
Nisalak et al., 2003). However, the virulence of DENV is difficult to measure due to 
a lack of in vivo and in vitro models of disease (Bennett et al., 2003).  
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Table 2.3 Susceptible cell types for DENV infection and DENV receptors. 
Species Cell types Origin of cells DENV receptor (s) References 
Human Huh Hepatocytes Heparan sulphate (SH) (Hilgard & Stockert, 2000; Lin et al., 2002) 
 HepG2 Hepatocytes Laminin receptor, GRP78, 
CLTC, DNM2, HS, 
(Alhoot et al., 2012; Jindadamrongwech et al., 2004; 
Thepparit & Smith, 2004) 
 K562 Hematopoietic 
cells 
nLc4Cer (Aoki et al., 2006) 
 Monocytes Primary 
myeloid cells 
CD14/LPS, HSP70/HSP90, 
Fc-receptor 
(Chen et al., 1999; Kliks et al., 1989; Kou et al., 2008; 
Reyes-Del Valle et al., 2005; Takada & Kawaoka, 2003) 
 Dendritic 
cells 
Primary 
myeloid cells 
DC-SIGN (Navarro-Sanchez et al., 2003; Tassaneetrithep et al., 2003) 
 Macrophages Primary 
myeloid cells 
Mannose receptor, CLEC5A (Miller et al., 2008) 
Insect C6/36 A. albopictus 
larvae cells  
Laminin receptor, HSP 
related, Prohibitin 
(Kuadkitkan et al., 2010; Sakoonwatanyoo et al., 2006; 
Salas-Benito et al., 2007; Salas-Benito & del Angel, 1997) 
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2.12 THE DENGUE VIRUS  
DENV is single stranded, positive sense RNA virus consisting of four 
antigenically distinct serotypes (DENV-1, 2, 3 and 4), belonging to the family 
Flaviviridae and genus Flavivirus. The length of the DENV genome is 
approximately 11Kb, which codes for three structural proteins [the capsid protein 
(C), a membrane associated protein (M) and an envelope protein (E)] and seven non-
structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5), which are 
flanked by the two untranslated regions (5
/
 and 3
/
 UTR) within a single open reading 
frame (Chambers et al., 1990; Rice, 1986).  
 
The E glycoprotein is the major surface component of the dengue virion 
surface, which is arranged as a smooth and dense lattice of 90 head-to-tail E 
homodimers (Kuhn et al., 2002). The E protein is the major target for neutralizing 
(Modis et al., 2005; Roehrig et al., 1998; Thullier et al., 2001) and protective 
antibodies (Kaufman et al., 1987). E protein contains four domains. These are the 
trans-membrane domain and domains I (the hinge region, containing the amino-
terminus), domain II (responsible for stabilizing the dimer and containing fusion 
peptide, amino acids 98-110) and domain III (Ig-like domain containing putative 
receptor binding motifs). The trans-membrane domain of E, which anchors domain 
III to the membrane, consists of three perimembrane helices E-H1, E-H2 and E-H3 at 
the N terminus and two trans-membrane helices E-T1 and E-T2, all interlinked by 
loops (Kuhn et al., 2002; Modis et al., 2003; 2004; 2005; Zhang et al., 2013). 
Domain I carries antigenic sites (Rey et al., 1995). Domain II contains a short amino 
acid sequence, which is highly conserved. This domain has an internal fusion peptide 
(Huerta et al., 2008). Domain III contains binding sites that help the virus to attach 
cellular receptors (Chin et al., 2007; Huerta et al., 2008).  
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DENVs utilize glycosaminoglycans (GAG), surface polysaccharides for 
attachment to host cells with as well as additional cellular receptors. The GAG 
binding motif occurs in the regions of the N terminus (amino acids 188, 284-295) on 
domain I/III and the C terminus of (amino acid 305-310) on the end surface of 
domain III (Chen et al., 1997). The recent identification of the host-cell receptors, 
mannose-specific C-type lectin and Dendritic-cell-specific ICAM3-grabbing non-
integrin (DC-SIGN) (Navarro-Sanchez et al., 2003; Tassaneetrithep et al., 2003), 
suggests that glycan- lectin interactions plays an important role in viral attachment. 
The glycosylation motif in the DENV E protein occurs in domain I, at residues N67, 
N153 and N64 (Modis et al., 2003). Evidence suggests that DENV infection of 
dendritic-cell-specific DC-SIGN receptors is mediated by the carbohydrate at N67 
(Pokidysheva et al., 2006). DENVs lacking the carbohydrate at position 67 showed 
reduced infection of immature dendritic cells (Mondotte et al., 2007). 
 
Due to the error prone nature of RdRps in the C-terminal domain of NS5, 
DENV raises significant genetic diversity during replication (Holmes & Burch, 
2000). Phylogenetic studies with each serotype showed diverse phylogenetic clusters 
that consist of multiple distinct lineages (Holmes & Twiddy, 2003; Weaver & 
Vasilakis, 2009). The most surprising features of DENV evolutionary dynamics are 
the lineage extinction and replacement on a regular basis (Holmes & Twiddy, 2003). 
Sometimes the lineage that persists for a number of years at a given location goes 
extinct, as an entirely new lineage takes over. Numbers of several studies have 
documented lineage replacement events on a regional scale (Table 2.4). Lineage 
replacement events on larger scales have also been reported in the Americas during 
the early 1990s (Rico-Hesse et al., 1997) where DENV-2 lineages from Southeast 
Asia displaced the American DENV-2 lineage. It is not clear whether the event of 
strain replacement is a result of random sampling of viral variants due to the 
stochastic nature of DENV transmission during genetic bottlenecks or due to the 
variation in fitness within populations. While it is unlikely that arboviruses that 
replicate best in vertebrates also will be the most fit when they infect mosquitoes, 
there have been no studies to determine how the distribution of fitness within 
arboviral populations changes during transmission. 
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Table 2.4 Lineage replacement events at different location.  
Serotype Year Country Reference 
DENV-1  Late 1990s Myanmar (Thu et al., 2004) 
DENV-1 Early 2000s Cambodia (Duong et al., 2011) 
DENV-1 Mid-1990s Thailand (Lambrechts et al., 2012; 
Zhang et al., 2005) 
DENV-2  Early 2000s Vietnam (Ty Hang et al., 2010) 
DENV-3 Late 1980s Sri Lanka (Messer et al., 2003) 
DENV-3 Early 1990s Thailand (Wittke et al., 2002) 
DENV-4 1980s and 1990s Puerto Rico (Bennett et al., 2003) 
 
Understanding the cause of DENV lineage extinction and replacement has 
important implications for dengue epidemiology and control because it is often 
associated with changes in disease incidence and severity (Gubler et al., 1978; 
Gubler et al., 1981; Lambrechts et al., 2012; Messer et al., 2003; Rico-Hesse et al., 
1997; Steel et al., 2010). Despite this potential significance, it is unclear what 
evolutionary forces are responsible for major lineage replacement events. Since most 
individuals in a viral population are less fit than the average fitness of the whole 
population (Duarte et al., 1994), the genetic bottlenecks produced by small numbers 
of mosquitoes in the dry seasons and the short half life of vectors even under optimal 
conditions are likely to result in a reduction of the fitness of the viral populations that 
are transmitted by the mosquitoes (Muller, 1964). As a large fraction of the 
mutations generated from RNA viruses during replication are deleterious (Duarte et 
al., 1994), repeated population bottleneck passages cause a decline in fitness. The 
introduction of the DENV vaccine may results in severe population bottlenecks by 
increasing herd-immunity among populations. However, the extent to which 
population bottlenecks affect on the fitness of DENV populations is not known. 
Exploring the drivers that shape DENV evolution and the factors responsible for 
expansion in human dengue infections is important to developing effective counter 
measures, especially when a licensed vaccine or antiviral therapies are absent. 
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2.13 KNOWLEDGE GAPS 
The following knowledge gaps have been identified:  
 
1) The mechanism responsible for DENV lineage turnover is not well 
understood.  
 
2) The impacts of population bottlenecks on DENV fitness have not been 
evaluated.  
 
3) Whether the cycles of replication of DENV in hosts of alternate species 
constrains viral evolution remains poorly understood. 
 
4) Is there a relationship between genetic diversity and fitness of DENV 
populations? 
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Chapter 3: MATERIALS AND METHODS  
3.1 CELL LINES AND HYBRIDOMAS 
Cell lines (Table 3.1) and hybridomas (Table 3.2) were maintained in RPMI-
1640 medium (Invitrogen) supplemented with 10% (v/v) heat-inactivated fetal 
bovine serum (FBS) (Invitrogen) and 1% (v/v) L-Glutamine (200mM) Penicillin 
(10,000 units) Streptomycin (10mg/ml) (Sigma). C6/36 cells were incubated at 30
0
C 
and all others including hybridomas were at 37
0
C in an atmosphere of 5% CO2/air 
Cells and hybridomas were passaged every 2 to 5 days. 
 
Table 3.1 List of cell lines used to grow DENV. 
Type of cell line Name of cell 
line 
ATCC * 
Identification 
Other 
Identification 
Aedes albopictus mosquito C6/36 CRL-1660  
Human hepatoma HepG2 HB-8065  
Human hepatoma Huh-7  JCRB
#
 cell 
bank; JTC-39 
Human hepatoma HC-04 MRA-975  
Human skin/muscle cells HS 1 CRL-7001  
Human synovial Sarcoma cells SW 982 HTB-93  
African green monkey kidney 
fibroblast  
COS-7 CRL-1651  
Human embryonic kidney HEK 293 CRL-1573  
Baby hamster kidney fibroblast  BHK 21 clone 
15 
 Morens et al., 
(1985) 
Human erythromyeloblastoid 
leukemia cells  
K562 CCL-243  
Human leukemic monocyte 
lymphoma  
U937 CRL-1593.2  
* The American Type Culture Collection; # Japanese Collection of Research Bioresources 
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Table 3.2 List of hybridomas used to identify DENV. 
Type of hybridoma Name of hybridoma Reference 
Anti- DENV-1 M10 Henchal et al., (1982) 
Anti-DENV-2 3H5 Henchal et al. (1982) 
Anti-DENV-3 5D4 Henchal et al. (1982) 
Anti-DENV-4 1H10 Henchal et al. (1982) 
 
3.2 VIRUSES  
Strains of DENV used in the study are shown in Table 3.3. Stocks of DENV 
were diluted 1 in 10 in RPMI-1640 and added to monolayers of C6/36 cell
 
for 2 
hours to allow virus attachment and internalisation. The volume of inoculum for 
infection was 2 ml for 25 cm
2 
flasks, 8 ml for 80 cm
2 
flasks and 15 ml for 175 cm
2 
flasks. Following infection, serum-free RPMI-1640 was added to the flasks and the 
cells were incubated at 30
o
C in 5% CO2/air for 7 days. The virus supernatant then 
was decanted from the flask into a 50 ml tube and centrifuged at 210xg for 10 
minutes to remove cell debris. The supernatant was supplemented with FBS to 20 % 
(v/v) and stored in 1 ml cryovials at -80
o
C. 
  
 Chapter 3: MATERIALS AND METHODS 45 
Table 3.3 Strains of DENV used. 
Serotype Strain Country Date of 
Isolation 
Accession 
number 
Passage 
number 
DENV-1 Hawaii Hawaii 1944 EU848545 Multiple, 
unknown 
 31459 Myanmar  1998 AY588272 P2 X C6/36 
 31987 Myanmar  1998 AY588273 P2 X C6/36 
 32514 Myanmar  1998 AY600860 P2 X C6/36 
 36957 Myanmar  2000 AY620951 P1 X C6/36 
 43826 Myanmar  2001 DQ264966 P1 X C6/36 
 44988 Myanmar  2002 AY726552 P1 X C6/36 
 47317 Myanmar 2002  P1 X C6/36 
 47662 Myanmar  2002 DQ265041 P1 X C6/36 
 49440 Myanmar 2002 DQ265137 P1 X C6/36 
 Infectious 
clone 
(49440)  
Myanmar 2002 - 1 X BHK, 1 X 
C6/36 
 62690 Myanmar  2005 - P1 X C6/36 
 62699 Myanmar  2005 - P1 X C6/36 
 63001 Myanmar 2005 - P1 X C6/36 
 68417 Myanmar 2007 - P1 X C6/36 
 75971 Myanmar  2009 - P1 X C6/36 
 77846 Myanmar  2009 - P1 X C6/36 
 80579 Myanmar 2009 - P1 X C6/36 
 84077 Myanmar  2009 - P1 X C6/36 
 84558 Myanmar  2009 - P1 X C6/36 
DENV-2 New 
Guinea C 
New Guinea 1944 AF038403 Multiple, 
unknown 
 Infectious 
clone 
(Gualano et 
al., 1998) 
New Guinea 1980 - 1 X BHK, 1 X 
C6/36 
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Table 3.3 Strains of DENV used (Continued). 
Serotype Strain Country Date of 
Isolation 
Accession 
number 
Passage 
number 
DENV-3 H87 Philippines 1956 M93130 Multiple, 
unknown 
 82899 Myanmar  2009 - P1 X C6/36 
 83468 Myanmar  2009 - P1 X C6/36 
 84014 Myanmar  2009 - P1 X C6/36 
 84700 Myanmar  2009 - P1 X C6/36 
DENV-4 H241 Philippines 1956 AY947539 Multiple, 
unknown 
 84087 Myanmar  2009 - P1 X C6/36 
 84711 Myanmar  2009 - P1 X C6/36 
 
3.3 PLAQUE ASSAY/CELL ELISA 
Monolayers of Cells in 96 well plates (Nunc) were infected with 200 µl tenfold 
dilution of DENV and incubated for 6 or 8 days. Culture supernatant from each 
culture was removed and cell monolayers were fixed with 5% (v/v) formaldehyde in 
phosphate buffer saline pH 7.2 (PBS) for 30 minutes at room temperature. After four 
washes with PBS containing 0.5% (v/v) Tween- 20 (Research Organics), 100 µl 
0.5% (v/v) triton X-100 (Merck) in PBS was added to the monolayers for 5 minutes 
at room temperature. After a further three washes with PBS-T, the cells were blocked 
with 2% (w/v) skim milk (Woolworths) in PBS for 30 minutes at room temperature. 
HRP labelled 6B6C-1 (Roehrig et al., 1982) was diluted 1 in 3000 with 2% (w/v) 
skim milk in PBS and 100 µl were added to each well and incubated for 1 hour at 
room temperature. Cells then were washed six times with PBS-T and 50 µl 3, 3’, 5, 
5’ tetramethylbenzidine (TMB) solution (ELISA Systems) was added. Positive wells 
contained infected cells that stained blue. Negative well contained uninfected cells. 
Infectivity titres were determined by endpoint dilution technique of Reed & Muench.  
Reed & Muench formula to calculate the index: 
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3.4 IMMUNOFLUORESCENCE ASSAYS 
Confluent adherent (C6/36, BHK-21 clone 15, HuH-7 and HS1) and non-
adherent (K562 and U937) cells in 12 well plates were infected with 200 µl DENV 
(DENV-1, -2, -3, -4) in serum-free RPMI-1640. After 1 hour of infection, 1 ml 
RPMI-1640 containing 2% v/v FBS was added to each well and incubated for 12 
days. Culture supernatant from each culture was removed after 12 days and 200 µl 
RPMI-1640 added to dislodge some of the cells monolayer. Suspensions of 
individual cells were prepared by repeated pipetting of the monolayers and the cells 
were diluted in approximately 1 ml RPMI-1640. Fifty microliters of cell suspensions 
from each dilution were added to each well of a 12 well, teflon coated, 
immunofluorescence slides (ICN Biomedicals). Excess liquid was aspirated form the 
spots and cells were air dried for 10 to 15 minutes at room temperature before being 
fixed in ice cold acetone for 4 minutes. Fifty microliters of a anti-DENV monoclonal 
antibody solution (M10 for anti- DENV-1, 3H5 for anti-DENV-2, 5D4 for anti-
DENV-3 and 1H10 for anti-DENV-4) (Henchal et al., 1982) were added to each spot 
and incubated for one hour at room temperature. The slides then were washed three 
times with PBS, each for 10 minutes. Fifty microliters of a secondary antibody 
solution composed of a 1 in 30 dilution of fluorescein isothiocyanate (FITC) labeled 
anti-mouse IgG (Dako) and a 1 in 80 dilution of FITC labeled rabbit anti-human IgM 
(Dako) in PBS was added to each spot and incubated for 45 minutes at room 
temperature. The slides were washed with PBS three times again each for 10 
minutes.  Cover slips were mounted on the slides and the cells examined on a 
fluorescent microscope (Eclipse, Nikon) using ploem illumination. The images were 
recorded using photometric CoolSnap (Nikon). Cells were considered infected if a 
clear green fluorescence was observed in the cytoplasm of the infected cells. 
Fluorescent and transmitted light images were recorded for each field. 
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3.5 INDIRECT ELISA 
Fifty microliters of supernatant from DENV infected, or uninfected cell 
cultures were diluted with an equal volume of chilled borate saline pH 9.0 (B.S) and 
added to 96 wells ELISA plates (Maxisorb, Nunc) at 4
o
 C for 24 hours. The plates 
then were washed five times with PBS-T and 100 µl of HRP-labelled 6B6C-1 diluted 
in 1 in 6000 in PBS-T was added to each well and incubated for 45 minutes at room 
temperature. The plates then were washed six times with PBS-T and 100 µl soluble 
TMB (ELISA Systems) was added to each well and incubated for 20 minutes for 
colour to develop. Fifty microliters of 1M sulphuric acid (H2SO4) was added to each 
well to stop the reaction. The absorbance in each well was determined with an 
ELISA plate reader (Beckman Instruments) at a wavelength of 450 nm against a 
blank of 620 nm.  
 
3.6 ASSAY FOR DISTRIBUTION OF FITNESS  
DENVs stocks were diluted two fold to provide a theoretical “one infectious 
unit” of virus as an input to individual cell cultures in 96 well plates i.e.~ 66 of the 
96 well C6/36 cells monolayers were infected to provide theoretical one infectious 
dose in every well. Two wells in each 96 well plate (A1 and B1) were infected with 
undiluted DENV as control (Figure 3.1). Eight days after infection, the culture 
supernatant from each of the 96 wells of cell culture was transferred into 
corresponding wells in a second 96 well plate. The amount of virus released from 
cells in each culture was determined by indirect ELISA in the second plate described 
previously (Figure 3.1). The cell monolayers in the original plate were stained for 
DENV E protein by cell ELISA as described previously. 
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Figure 3.1 Distribution of fitness within populations of DENV-1. Serial dilutions of DENV were added to 94 wells of 96 well plates containing 
monolayers of C6/36 cells. Undiluted virus was added to the two remaining wells shown within bracket. Eight days later the supernatants from 
the cultures were transferred to 96 well ELISA plates and the cell monolayers stained for DENV antigen by indirect ELISA. The amount of 
DENV in each supernatant was quantified by indirect ELISA. 
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3.7 ALTERNATE PASSAGEING OF DENV IN HUMAN AND MOSQUITO 
CELLS 
Two different experimental schemes involving infections of either diluted or 
undiluted infection were applied to passage DENV in mosquito (C6/36) and human 
(HuH7) cells alternatively. For bottleneck passage, a log10 dilution series of virus 
was prepared and used to infect confluent monolayers of C6/36 and HuH7cells in 
T25 flasks and corresponding 96 well plates, respectively (Figure 3.2). The flasks 
and the plates were incubated at 30   for C6/36 cells and 37  for HuH7 cells. After 
6 days, the number of positive wells in 96 well plates was identified by cell ELISA 
described previously. The plates where ~ 66% wells in 96 well plates were positive 
by cell ELISA were considered as virus in bottlenecked (Figure 3.2). Viruses in T25 
flasks corresponding 96 well bottlenecked plates were chosen for alternated 
passages. For undiluted passages, viruses were passaged alternatively in C6/36 and 
HuH7 cells without dilution (Figure 3.2).  
 
Ten millilitres and 20 ml were used to infect alternate cells in T25 flasks and 
96 well plates, respectively. Ten millilitres of culture supernatant infected with 
undiluted virus were diluted up to 35 ml with RPMI containing 5% FBS. Five 
millilitres of viruses were aliquoted and stored at -80  for future use. Viruses were 
passaged alternatively up to five times without storing in the freezer in order to 
prevent any loss of titres. Titre of the viruses was determined in alternate cell line 
and expressed as log10TCID50/ml. 
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Figure 3.2 Alternate passaging of DENV in mosquito and human cell lines. DENV were passaged either 
undiluted or dilute series.   
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3.8 REVERSE TRANSCRIPTION- POLYMERASE CHAIN REACTION 
(RT-PCR) 
3.8.1 RNA Extraction  
RNA was extracted from 140 µl samples of virus using the QIAamp Viral 
RNA mini kit (Qiagen), according to the manufacturer’s instructions.  
 
3.8.2 RT-PCR for Detection of NS5 and Defective Interfering (DI) Particles   
Complementary DNA (cDNA) was produced from the RNA of DENV using 
random hexanucleotide primers (Boehringer Mannheim) and expand reverse 
transcriptase (Expand RT; Roche). Briefly, 1 µl random hexamer primers (200ng/µl) 
was added to 11 µl RNA in a 0.5 ml tube (LabAdvantage) and the mixture was 
incubated at 72
o
C for 10 minutes in a heating block before being placed on ice for 2 
minutes. Four microliters of 5x RT buffer (Roche), 1 µl 100mM DTT (Roche), 1 µl 
10mM dNTPs (Roche), 1 µl RNAse inhibitor (40 unit/µl; Roche) and 1 µl expand 
RT (50 unit/µl) were added to the tube and the volume made up to 20 µl with 
nuclease free water. RT reactions were incubated in a thermocycler (Gene works) at 
50
o
C for 1 hour and then 85
o
C for 10 minutes. The primers (Table 3.4) used for PCR 
amplification corresponded to conserved regions of the DENV-1 NS5 gene. Five 
microliters of 10x PCR buffer (Roche), 1 µl 10mM dNTP, 1 µl forward primer 
(100ng/µl), 1 µl reverse primer (100ng/µl), 0.5 µl taq DNA polymerase (5 unit/µl; 
Roche), 4 µl cDNA and 38 µl nuclease free water were mixed in a 0.5 ml tube to 
make the total volume of 50 µl.  PCR was performed in an MJ thermocycler using 
cycling conditions of 94
0
C for 2 minutes for one cycle and then 94
o
C for 30 seconds, 
56
o
C for 30 seconds and 72
o
C for 2 minutes run for 38 cycles followed by 72
o
C for 
10 minutes for final extension. 
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To detect defective interfering (DI) particles (RNA <2000 nt), cDNA was 
generated as described above using random primers. The primers (Table 3.4) used 
for PCR amplification corresponded to a region of the DENV-1 5
/
 untranslated 
region (UTR) forward and 3
/
 UTR reverse (Li et al., 2011). Twenty five microliter 
reaction volumes were prepared by combining  2.5 µl 10x PCR buffer, 0.5 µl 10mM 
dNTP, 0.5 µl 5
/
UTR-F (100ng/µl), 0.5 µl 3
/
UTR-R (100ng/µl) primers, 0.05 µl Taq 
DNA polymerase (5 unit/µl), 2 µl cDNA and 19 µl nuclease free water. Thermal 
cycling was performed at 94
o
C for 2 minutes for one cycle and then 94
o
C for 20 
seconds, 56
o
C for 30 seconds and 72
o
C for 2 minutes for 40 cycles and then 72
o
C for 
10 minutes for final extension. The 2 minute extension time ensured only genomes 
with large internal deletions were amplified.  
 
Table 3.4 Primers employed for PCR. 
Primer 
Name 
Sequence (5
/
- 3
/
) Genome 
position 
Gene 
D1-7927F CTATGGATGGAACCTAGTAAAGC 7927-7950 NS5 
D1-9544R CAGTCATCTACGCTGATTGCC 9544-9565 NS5 
D1 5
/
 UTR AGTTGTTAGTCTACGTGGACC 1-21 5
/
 UTR 
D1 3
/
 UTR ATTGTCGACCAGCCCGGGTGAACCT
GTTGATTCAAC 
10717-
10736 
3
/
 UTR 
 
 
3.8.3 Agarose Gel Electrophoresis 
One microliter of 10x loading buffer (Invitrogen) was added to 5 µl PCR DNA 
and loaded onto 1.5% (w/v) agarose (Boehringer Mannheim) in 1x Tris-
acetate/EDTA (TAE) buffer containing 0.2 µg/ml ethidium bromide (Sigma) and 
electrophoresed for 45 minutes at 100 volts to determine the size of the PCR product 
using DNA MW marker XIV (50ng/µl; Roche). 
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3.9 SEQUENCING  
3.9.1 Complete Genome Sequencing 
Ten sets of DENV-1 primers (Table 3.5) were selected for PCR amplification. 
RT-PCR was performed as described above, but with the following modifications. 
Mixture of RNA and primers were incubated at 65
o
C for 5 minutes in a heating block 
and then was placed on ice for 2 minutes. RT reactions were incubated 50
o
C for 1.5 
hours. 
 
Table 3.5 Primers employed for amplification of complete genome of DENV-1. 
Primer set Primer 
name 
Sequence (5
/
- 3
/
) Gene 
1 D1 1F GTGGACCGCAAAGAACAG 5
/
 UTR 
D1 1063R GTCTTCAAGAGTTCAATGTC E 
2 D1 789F CTCTGAGACACCCAGGATTCAC prM 
D1 843F ATGCCATAGGAACATCC prM 
D1 1830R CTGTGCACATCACATATGAC E 
3 D1 1645F CAGCTCATGCAAAGAAGCAGGA E 
D1 2465R TTGGTGACAAAAATGCC NS1 
D1 2843R CTCTTTGGTCATCAGAGCATTC NS1 
4 D1 2554F GGGAGGAGGGTGTGTGTG NS1 
D1 3972R CCATAGCCATTGTCTTCCATG NS2A 
5 D1 3828F CTAGGGGATGGACTTGCAATC NS2A 
D1 3851F GGACTTGCAATGGGCATTATG NS2A 
D1 4793R CTGCACTTCTTCTCCCGTGTTC NS3 
6 D1 4728F GACCTGATCTCATATGGAGGAG NS3 
D1 4987R GACGTAGGTTCCACTTGTTG NS3 
D1 6073R TCCCCGTCTATTGCTGCACTC NS3 
7 D1 5958F GATCACGCTCATTGGACAGAAG NS3 
D1 7192R GCAGTCCAGGTCCAATTATG NS4B 
8 D1 7026F CAGGCAGCTATATTGATGGGAC NS4B 
D1 8023R GTTGGGTTCGGAGAGGA NS5 
9 D1 7913F CTATGGATGGAACCTAGTAAAGC NS5 
D1 9179R CTGTTATTCTTGTATCCCATCC NS5 
10 D1 8962F GAAGTCGTGCAATATGGTACATG NS5 
D1 10247R CGGGATCGCTCTCGTTCTTG NS5 
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Five microliters of 10x Expand high fidelity PCR buffer with 15mM MgCl2 
(Roche), 1 µl 10mM dNTP, 2 µl forward primer (100ng/µl), 2 µl reverse primer 
(100ng/µl), 0.75 µl Expand high fidelity PCR system (3.5 unit/µl; Roche), 5 µl 
cDNA and 34.25 µl nuclease free water were mixed to make the total volume of 50 
µl.  PCR was performed using cycling conditions of 94
o
C for 2 minutes for one cycle 
and then 92
o
C for 30 seconds, 58
o
C for 40 seconds and 68
o
C for 2.30 minutes for 10 
cycles, 92
o
C for 30 seconds, 58
o
C for 30 seconds and 68
o
C for 3 minutes for 10 
cycles, 92
o
C for 30 seconds, 58
o
C for 30 seconds and 68
o
C for 3.30 minutes for 18 
cycles run for 39 cycles followed by 68
o
C for 10 minutes for final extension.  
 
3.9.2 Purification of PCR Products for Automated Sequencing 
PCR products were electrophoresed on 1.0% agarose in 1x TBE buffer and 
products of the correct size were gel purified with the MinElute PCR purification kit 
(Qiagen), according to the manufacturer’s instructions except a few modifications. 
Ten or twenty microliters of TE buffer was added to the centre of the MinElute 
membrane. After one minute incubation at room temperature the column was 
centrifuged for 1 min at 13000 rpm to elute the DNA from the membrane. DNA was 
purified separately for each DENV to avoid cross contamination. The work bench 
was cleaned with ethanol spray before and after purification of each DENV. Separate 
gels, scalpels and gloves were used for each purification step. One microliter of 
eluted purified product was used to measure concentration by spectrophotometry and 
one microliter was also run in an agarose gel to compare the concentration with the 
DNA MW XIV (100ng/µl). 
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3.9.3 Automated Sequencing of the PCR Products 
The purified PCR products were sequenced using the oligonucleotide primers 
outlined in Table 3.5. The purified DNA (100 ng per 300 bp of product) was added 
to 3.2 pmol of oligonucleotide primers (forward and reverse) in a final volume of 12 
µL. The remaining sequencing reaction was performed by Australian Genome 
Research Facility Ltd (AGRF), Brisbane. Sequencing was performed on automated 
ABI 3730 DNA Analyzer (Applied Biosystems) using dye-terminator chemistry. 
 
3.9.4 Sequence Alignments 
The nucleic acid sequences derived from alternate passaging experiments were 
aligned with one another for each DENV gene and with published DENV sequence 
M31987 (Accession no. AY588273). Alignments were performed using the 
ClustalW program of the Geneious Pro software.  
 
3.9.5 Phylogenetic Analysis 
The aligned nucleic acid sequences were used to construct bootstrapping 
phylogenetic tree using the Neighbor-joing tree building method and Tamura-Nei 
genetic distance model of the Geneious Pro software.  
 
3.9.6 RT-PCR for Roche/454 FLX Sequencing 
RT-PCR was performed as described above, but with the following 
modifications. RNA was quantified by spectrophotometry. Equal amounts of RNA 
were used for RT. Mixtures of RNA and primers were incubated at 65
0
C for 5 
minutes in a heating block and then were placed on ice for 2 minutes. RT reactions 
were incubated 55
o
C for 1.5 hours.  
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The primers (Table 3.6) used for PCR amplification corresponded to a region 
of the prM-E-NS1 of DENV-1. Five microliters of 10x Expand high fidelity PCR 
buffer with 15mM MgCl2 (Roche), 1 µl 10mM dNTP, 2 µl forward primer 
(100ng/µl), 2 µl reverse primer (100ng/µl), 1.5 µl Expand high fidelity PCR system 
(3.5 unit/µl; Roche), 6 µl cDNA and 32.5 µl nuclease free water were mixed in a 0.6 
ml tube to make the total volume of 50 µl.  PCR was performed using cycling 
conditions of 94
o
C for 2 minutes for one cycle and then 94
o
C for 30 seconds, 58
o
C 
for 45 seconds and 68
o
C for 3.50 minutes run up to 40 cycles and 68
o
C for 10 
minutes for final extension. PCR was run from the same reaction for all DENV in 
duplicate at a time. DNA was purified from gel using the MinElute PCR purification 
kit (Qiagen), according to the previous described protocol (see above).  
 
PCR amplicons were quantified by spectrophotometry. Genome fragments of 
individual strains amplified from the same PCR reaction were pooled in equimolar 
amounts to obtain equal coverage, and submitted for library preparation before 
subsequent next-generation sequencing (NGS) using 454 Roche FLX Titanium at the 
Murdoch University, Perth, Australia. Briefly, amplicons were sheared using 
nebulization to average fragment size of 800bps. The samples were then taken 
through library preparations using the rapid library multiplex identifier adaptors in 
order to enable sample identification following sequencing on the FLX genome 
sequencer. Samples were then pooled together and taken through emulsion PCR and 
run on 1/8th region of a FLX titanium chemistry sequencing run.  
 
Table 3.6 Primers employed for amplification of prM-E-NS1 fragment of DENV-1. 
Primer 
Name 
Sequence (5
/
- 3
/
) Genome 
position 
Gene 
D1-330F AAGTGCTACGGGGTTTCAAG 330-350 Capsid 
D1-3462R GACCCTGCAGAGACCATTG 3462-3480 NS2A 
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3.9.7 454 FLX Data Alignment 
454 FLX sequence alignment was performed by Dr. Fabio Luciani, University 
of New South Wales (Bull et al., 2011). Briefly, the sequence reads were not used for 
assembly stage if they were shorter than 55 bp and had an average quality score <20. 
The terminal 20 nt were removed from all remaining reads. These remaining 
sequences were aligned with a nucleotide identity threshold of 95% against each 
subject's unique consensus sequence with the alignment tool, MOSAIK 
(http://bioinformatics.bc.edu/marthlab/Mosaik). The recommended parameters for 
454 data were used in aligning these reads. E gene consensus sequence of each 
subject's was derived from sequencing the gel purified PCR products on the ABI 
3730 DNA sequencer (Applied Biosystems). Full length consensus reference 
sequence (AY726549) generated on the ABI 3730 DNA sequencer. The quality of 
the aligned file was assessed and reads were excluded from the alignment on the 
following basis: i) hypermutated sequence (sequences with more than 5 nt mutations 
within the first 20 position of the read in either of the ends; ii) reads with indels that 
resulted in a frame-shift or reads with a high frequency (5%) of indels relative to the 
reference. 
 
3.9.8 Haplotype Reconstruction 
Haplotypes were reconstructed by Dr. Fabio Luciani, University of New South 
Wales (Bull et al., 2011). Briefly, aligned 454 reads were further analysed with a 
Bayesian probabilistic method implemented in the software package ShoRAH 
(Zagordi et al., 2010a; Zagordi et al., 2010b). This software was used to perform 
error correction on 454 reads, to estimate the distribution of SNPs and their 
prevalence, using a detection threshold of 0.1%, to reconstruct DENV haplotypes on 
the envelope region of the DENV-1 genome (~1500 nt in length), and to estimate the 
frequency of occurrence of reconstructed variants within the sample. The ShoRAH 
analyses were performed in triplicate for each dataset to ensure that the stochastic 
nature of Bayesian statistics based on Monte Carlo Markov Chain simulations was 
not affecting the results. Only SNPs and variants detected in all the three simulation 
runs were considered for further analyses. 
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Further automated cleaning of the SNPs generated via the ShoRAH method 
was performed, based on the following criteria: (i) sequences where the reverse and 
forward strand differed in a frequent base substitution, allowing only a difference of 
10% between forward and reverse reads; (ii) SNPs that were only present at the end 
of reads; and (iii) if the nucleotides adjacent to the SNP were part of a 
homopolymeric stretch.  
 
For the analysis of the Envelope region of the genome, only reconstructed 
variants with frequencies >2.5% were considered for further analysis. The 
probabilistic nature of the clustering algorithm allows for estimation of the reliability 
of predictions. In the Bayesian scenario implemented in ShoRAH, the fraction of 
iterations in which a haplotype is reported estimates the posterior probability of the 
existence of that haplotype. This posterior probability provides a confidence level for 
the haplotype. Only haplotypes with confidence values (posterior probabilities) 
greater than 0.9 are reported.  
 
3.9.9 Sequence Alignments and Phylogenetic Analysis 
Alignment of haplotype sequences derived from 454 reads was performed 
using the ClustalW program of the Geneious Pro software. The aligned nucleic acid 
sequences were used to construct bootstrapping phylogenetic tree using the 
Neighbor-joing tree building method and Tamura-Nei genetic distance model of the 
Geneious Pro software.  
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3.9.10 Highlighter Plots and 3D Macromolecular Structures 
Highlighter plots were used to highlight mismatches between nucleotide and 
amino acid sequence haplotypes derived from 454 reads. Highlighter plots were 
performed by using the Gnuplot program in the website (Los Alamos National 
Laboratory website-HIV Sequence Database, 
http://www.hiv.lanl.gov/content/sequence/HIGHLIGHT/highlighter.html).  
Sequence-structure relationship of DENV E protein was examined with known 
DENV structure from NCBI. Cn3D program was used to visualization of three-
dimensional structures of DENV E protein.  
 
3.10 STATISTICAL ANALYSIS 
Statistical analysis was performed using the Minitab statistical package. P 
values lower than 0.05 were considered statistically significant. 
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Chapter 4: RESULTS 
4.1 PHYLOGENETIC RELATIONSHIP BETWEEN DENV-1 ISOLATES 
A phylogenetic analysis of Myanmar DENV-1 E gene sequences from 
Genbank and unpublished sequences from our laboratory produced a tree with five 
distinct branches (Figure 4.1). Lineage A contained the first example of DENV-1 
recovered in Myanmar (Burma, Bur76 and Mya76) and this lineage became extinct 
in 1998 at about which time lineages B and C appeared. No examples of lineage B 
have been recovered since 2002 but lineage C was still circulating in 2008. Lineage 
D was detected first in 2006 and was still circulating in 2008. The single example of 
lineage E, which was most closely related to DENV-1 from Vietnam (unpublished 
observations), did not appear to have established cycles of transmission. The strains 
in bold type in Figure 4.1 were regarded as representative of their lineage and were 
used in subsequent studies.  
 
4.2 SUSCEPTIBILITY OF VERTEBRATE AND INVERTEBRATE CELL 
LINES TO INFECTION WITH DENV 
Because subsequent studies required that DENV be grown in both mosquito 
and relevant human cell lines, an analysis  of the susceptibility of C6/36 (mosquito) 
and a range human cell lines (HuH7, HepG2, HC04, K562, U937, HS1 and SW987) 
to infection with DENV serotypes and genotypes was undertaken. Baby Hamster 
kidney (BHK-21) cells were included as a control substrate.  
With the exception of HuH7 cells, the human cell lines were uniformly, 
refractory to infection with prototype strains of DENV (Table 4.1). 
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Figure 4.1 Phylogenetic analysis of the E gene of DENV-1 showing Lineage 
extinction and replacement of DENV-1 in Myanmar. Bootstrap values (100 
replications) for key nodes are shown. A distance bar is shown below the tree. 
Lineage A, B and E are extinct and lineage C and D are still circulating. Strains 
selected for study have been highlighted. 
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Table 4.1 Replication of DENV serotypes in vertebrate and invertebrate cell lines. 
Cell line Percentage of cells infected with prototype DENV serotypes at 
the time of peak viraemia (titres in culture supernatant 
[log10TCID50/ml]) 
DENV-1 DENV-2 DENV-3 DENV-4 
C6/36 57 (5.5) 61 (6.5) 82 (6.5) 58 (5.5) 
HuH7 0 (<1.0) 21 (2.5) 12 (2.5) 10 (2.5) 
HepG2 n.d (<1.0) n.d (1.0) n.d (<1.0) n.d (<1.0) 
HC 04 n.d (<1.0) n.d (<1.0) n.d (<1.0) n.d (<1.0) 
K562 0 (n.d) 1 (n.d) 0 (n.d) 0 (n.d) 
U937 0 (n.d) 2 (n.d) 0 (n.d) 0 (n.d) 
HS1 n.d (<1.0) n.d (4.5) n.d (<1.0) n.d (<1.0) 
SW987 n.d (<1.0) n.d (1.0) n.d (<1.0) n.d (<1.0) 
BHK-21 69 (3.5) 88 (6.5) 46 (3.5) 41 (3.5) 
293T n.d (<1.0) n.d (<1.0) n.d (<1.0) n.d (<1.0) 
COS7 n.d (<1.0) n.d (4.5) n.d (1.5) n.d (<1.0) 
n.d. not determined 
 
 
In the light of the results in Table 4.1, subsequent experiments with low 
passage Myanmar DENV isolates and other DENV populations of interest were 
performed only in C6/36 and HuH7 cells (Table 4.2). An additional variable was the 
use of FBS in a culture medium. Some subsequent analyses would have been easier 
to perform if DENV could be grown in serum-free cell culture. There was little 
difference between the yield of DENV from C6/36 cells cultured with, or without, a 
FBS supplement (Table 4.2). As observed in the previous experiments, the yield of 
DENV from HuH7 cells was consistently lower than that from C6/36 cells. No 
detectable DENV production occurred in HuH7 cells infected with 8/20 DENV 
strains studied. Of the remainder, the highest yields of DENV occurred in cultures, 
which included FBS in the culture medium.  
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Table 4.2 Susceptibility of mosquito (C6/36) and human (HuH7) cell lines to 
infection with DENV. 
Dengue virus Titre of virus inoculum producing infection of 
monolayer (log10TCID/ml) 
Serotype Strain  C6/36 
without 
FBS 
C6/36 with 
FBS 
HuH7 
without 
FBS 
HuH7 with 
FBS 
DENV-1 Hawaii 6.5 5.5 <1.0 <1.0 
 31459 7.0 6.5 <1.0  2.0  
 31987 5.5 5.0 <1.0 3.0 
 32514 7.0 6.5 3.0 3.0 
 62699 6.0 4.5 <1.0  <1.0 
 63001 5.5 5.0 <1.0  2.0 
 75971 5.5 5.5 <1.0 2.0 
 84077 8.0 7.5 3.0 3.0 
 84558 7.5 7.0 <1.0 2.0 
 I. C  7.5 7.0 <1.0 4.0 
DENV-2 New Guinea C 8.0 8.0 4.0 4.0 
 I. C  8.0 8.0 4.0 4.0 
DENV-3 H87 7.5 7.5 <1.0 2.0 
 82899 7.0 5.5 <1.0 <1.0 
 83468 5.0 4.5 <1.0 <1.0 
 84014 7.0 6.5 <1.0 <1.0 
 84700 4.5 3.5 <1.0 <1.0 
DENV-4 H241  7.0 7.0 <1.0 2.0 
 84711 6.5 5.5 <1.0 <1.0 
 84087 7.0 6.5 <1.0 <1.0 
I.C. Infectious clone derived DENV-2 
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4.3 YIELDS OF DENV IN CULTURES OF MOSQUITO AND HUMAN 
CELLS 
While the previous experiments suggested that C6/36 mosquito cells were as 
much as one million times more sensitive to infection with low passage strains of 
DENV-1, they provided no information about the amount of DENV produced by 
these cells once infected. Two additional pieces of information were required for 
subsequent studies, which had been planned. These were the effect of multiplicity of 
infection (m.o.i.) on the kinetics of release and the yield of virus from cultures 
infected with these Myanmar strains of DENV-1. 
Monolayers of C6/36 cells in 96 well plates were infected with 10-fold 
dilutions of DENV and aliquots removed at intervals of two days for quantitation of 
virus production by ELISA (see Materials and Methods). Peak titres of prototype 
strains were detected approximately 8 days after infection. Peak titres of the DENV-1 
strains from the Myanmar patients also were detected approximately 8 days post-
infection (Figure 4.2– 4.6). However, the peak titres of virus often were not produced 
by cultures infected with the highest concentration of virus (e.g. Figure 4.4 c, d; 
Figure 4.5 b, d). Although the issue was not explored extensively here, these results 
are compatible with the presence of defective interfering (D.I.) particles in these 
virus preparations (Li et al., 2011). As these experiments were performed at different 
times, albeit using the same protocols, it was not possible to make statistical 
comparisons of the titres of the extracellular virus produced by C6/36 cells infected 
with the various strains of DENV-1. 
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Figure 4.2 Yield of prototypes strains of DENV in cultures of A. albopictus (C6/36) cells infected with ten-fold dilutions of (a) DENV-1, (b) 
DENV-2, (c) DENV-3  and (d) DENV-4 ( 10-1,  10-2, ▲ 10-3,  10-4,  10-5,  10-6 and  10-7).  
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Figure 4.3 Yield of virus in cultures of C6/36 cells infected with ten-fold dilutions of DENV-
1 lineage A (M32514;  10-1,  10-2, ▲ 10-3,  10-4,  10-5,  10-6 and  10-7). 
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Figure 4.4 Yield of virus in cultures of C6/36 cells infected with ten-fold dilutions of DENV-1 lineage B; (a) M31459, (b) M36957, (c) M43826 
and (d) M44988 ( 10-1,  10-2, ▲ 10-3,  10-4,  10-5 and  10-6  10-7).  
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Figure 4.5 Yield of virus in cultures of C6/36 cells infected with ten-fold dilutions of DENV-1 lineage C; (a) M31987, (b) M47317 (c) M47662 
and (d) M49440 ( 10-1,  10-2, ▲ 10-3,  10-4,  10-5,  10-6 and  10-7).  
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Figure 4.6 Yield of virus in cultures of C6/36 cells infected with ten-fold dilutions of DENV-1 lineage C; (e) M62690 and lineage D; (f) 
M68417 ( 10-1,  10-2, ▲ 10-3,  10-4,  10-5 and  10-6). 
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To investigate why the highest levels of virus in culture supernatants were not 
from cultures infected with the most viruses, RNA was extracted from stocks of 
viruses M47317, M47662, M43826, M36957, M44988, M31987, M31459 and 
M32514 and amplified by RT-PCR to detect short pieces of RNA, such as those 
found in DI (see Materials and Methods). A highly conserved region of the NS5 gene 
(nt 7927 to 9565) was amplified as a surrogate for full length genomes. DI particles 
and NS5 were amplified from the cDNA in the same samples. The ratio of DI 
particles was compared with NS5. DI particles were detected in populations of 
DENV-1 (Figure 4.7) in which greater virus production occurred when C6/36 cells 
were infected with dilute virus stocks (e.g. Figure 4.4, strain M44988 and Figure 4.5, 
strain M47317) and in populations in which this effect was not observed (e.g. Figure 
4.4, strains M31459 and Figure 4.5, strain M31987) suggesting that other influences 
also are at play to down regulate virus production e.g. full length genomes with less 
extensive defects than those seen in DI particles (Aaskov et al., 2006). 
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Figure 4.7. Agarose gel electrophoresis of cDNA generated by RT-PCR of genomes from 
populations of DENV-1. 
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In the previous section, DENV production in cell culture was measured by 
ELISA in order to detect all virions released from infected cells irrespective of 
whether or not their genome was functional. The earliest experiments were repeated 
with cultures of C6/36 cells being infected with stocks of the strains of DENV-1 of 
interest and the yield of viruses in the culture supernatant quantified by ELISA (as 
previously) or by titration of infectivity on monolayers of C6/36 cells. ELISA 
allowed greater discrimination between levels of virus production than did titration 
of infectious virus. Cultures producing the most virions (ELISA) did not always 
produce the most infectious virus (Figure 4.8).  
 
The data in Table 4.1 illustrated how refractory HuH7, and other human cell 
lines, were to infection with low passage DENV-1. To determine what yield of virus 
these cells might produce, monolayers of HuH7 cells were infected with undiluted 
stocks of DENV-1 and yields of infectious virus in the culture supernatant assayed at 
intervals of two days on C6/36 cells. In most instances, there was only an increase of 
1-2 log10 in the titre of the virus after day 2 (Figure 4.9). Virus present at day 2 was 
most likely residual virus remaining after the initial infection. 
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Figure 4.8 Yield of viruses in cultures of C6/36 cells infected with DENV-1 strains 
( M31459,  M31987, ▲ M32514,  M36957,  M43826,  M47662,  
M49440, — M62690, — M68417,  M80579). (a) Extracellular virus quantified by 
indirect ELISA (b). Extracellular virus quantified by titration of infectivity in C6/36 
cells.   
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Figure 4.9 Yield of viruses in cultures of HuH7 cells infected with DENV-1 strains 
( M31459,  M31987, ▲ M36957,  M44988, M47317,  M47662,  
M49440,  M68417,  M80579 and  DENV i. c). Titres were measured in C6/36 
cells.  
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4.4 DISTRIBUTION OF FITNESS WITHIN POPULATION OF DENV-1 
The original plan had been to compare the distribution of fitness within the 
populations of Myanmar DENV-1 on both human and mosquito cells. However, the 
large amounts of virus required to infect the human cell lines (high m.o.i.) rendered 
these experiments impossible to perform in many cases and any results obtained 
from these cells would have been almost impossible to interpret. The experiments 
following have, therefore, been performed only on C6/36 cells.  
Stocks of viruses from the four lineages in Figure 4.1 (A, B, C, D) were limit 
diluted to provide a theoretical “one infectious unit”/200 µl inoculum (i.e. 65 of the 
96 wells contained infectious virus) and used to infect monolayers of C6/36 cells in 
96 well plates. Eight days after infection, at the time of peak virus production (Figure 
4.2-3.6), the amount of virus released from C6/36 cells in each well was determined 
by indirect ELISA (Figure 3.1). The absorbance (amount of virus) from cultures 
infected with one infectious dose of virus was compared with that of the population 
from which it was derived (control) i.e. cell monolayers in the 96 well plate infected 
with corresponding undiluted stock virus. The mean absorbance (± 2 s.d) was 
calculated for the duplicate control wells containing undiluted stock of the DENV-1 
population being analysed (A1, B1; Figure 3.1). Supernatants from cultures giving 
rise to an ELISA absorbance similar to the mean (± 2 s.d) for cultures A1, B1 
(undiluted stocks of virus) were regarded as having the same fitness is the population 
from which they were derived. Supernatants from cultures giving rise to an ELISA 
absorbance more than 2 s.d less than the mean for cultures A1 and B1 were regarded 
as less fit. Supernatants from cultures giving rise to an ELISA absorbance more than 
2 s.d greater than the mean for A1 and B1 were regarded as more fit. The distribution 
of fitness within populations of DENV-1 (lineages A, B, C and D) is shown in Figure 
4.10.  
Less than 2 per cent (fewer than 1 in 94) of the members of DENV-1 
populations collected in 1998 (in lineages A, B, C) were more fit than the population 
from which they were drawn i.e. produced as much as, or more, virus in cultures than 
did the undiluted population from which they were drawn (Figure 4.10). Members of 
all populations recovered after 1998 contained some members that were more fit than 
the population from which they were derived except for the sample recovered in 
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2000 (36957/00, lineage B) which showed an increase in the prevalence of more fit 
members. 
Most of the post-1998 samples, including lineage D, were recovered after the 
explosive outbreak of DENV-1 infection in Myanmar in 2001 showed an increase in 
the prevalence of more fit members. While DENV populations of both lineages B 
and C appeared to be gaining more fit members, only lineage C has survived. Strains 
in lineage D, which appeared after the outbreak, already contained members that 
were more fit than the population from which they were drawn. 
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Figure 4.10 Distribution of fitness within populations of DENV-1 from four 
lineages. Populations are identified as strain/year/E (extinct) or C (circulating); 
proportion more fit than the population average indicated horizontal hatch, same fit 
as the original population indicated as bold squares and less fit than the original 
population indicated as small squares. 
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4.5 LINEAGE TURNOVER AND GENETIC DIVERSITY OF DENV-1 
The previous experiments, which examined the phenotypic properties of 
DENV populations and their members, failed to provide an explanation for the 
lineage extinctions observed in nature. The growth kinetics of some populations 
shown in Figure 4.4 and 4.5, which were compatible with the presence of defective 
interfering particles, raised the broad issue of the nature and magnitude of the genetic 
diversity in these populations i.e. whether lineages that became extinct may have 
been accumulating large numbers of deleterious mutations. A region of the DENV 
genome spanning the prM-E-NS1 genes was amplified by RT-PCR and sequenced 
by 454 pyrosequencing. Haplotypes were reconstructed for the E gene of each 
DENV-1 population. Twelve samples were sequenced, but two of them, M80579 and 
M62690, were excluded from this study because of low coverage and problems with 
assembly.  
A phylogenetic tree was constructed with the consensus nucleotide sequences 
for the E gene for each DENV-1 population and the sequences of each haplotype 
identified (Figure 4.11). With the exception for the strain M47317, each haplotype 
segregated with the consensus sequence for the population from they were drawn. 
The intermediate position of the consensus sequence for M47317 in this tree, and 
previously (Figure 4.1), suggests that it could have been derived from a recombinant 
genome and the haplotypes may represent selective amplification of a parental sub-
population during RT-PCR to prepare cDNA for 454 sequencing (Figure 4.12). 
Alignment of the consensus nucleotide sequences for representative strains from 
clades B and C with that for M47317 and the sequences of M47317 haplotypes 
suggested a recombination break point at about nucleotide 1040 (Appendix C). 
Phylogenetic trees constructed with sequences from either side of this point 
supported this conclusion i.e. nt 1-1040 of the consensus sequence of M47317 
segregated with those from lineage C viruses (Figure 4.12 a) while sequences 3
/
 to 
this point segregated more closely with lineage B viruses and the M47317 haplotypes 
(Figure 4.12 b)  
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Figure 4.11 Phylogenetic analysis of the E gene haplotype and consensus sequences 
of DENV-1. Consensus sequences for each strain have been highlighted. Bootstrap 
values (100 replications) for key nodes are shown. A distance bar is shown below the 
tree. Lineage A and B are extinct and lineage C and D are still circulating. 
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Figure 4.12 Phylogenetic analyses of nt 1-1040 and nt 1041-1485 of the consensus sequences of the E genes of DENV-1 from lineages B and C 
and of the sequences of the same regions of the E genes of M47317 haplotypes. Bootstrap values (100 replicates) for key nodes are shown. 
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The number of nucleotide changes, the nature of the change (relative to the 
sequence of the most common haplotype) and the distribution of these changes 
within the E gene are shown in Figure 4.13 - 4.16. The values for these changes are 
shown in Table 4.3. Values for strain M47317 have been excluded from the analyses 
that follow because of the disparity between the positions in the phylogenetic tree of 
the sequences of the haplotypes and the consensus sequence. There was no 
significant difference (p> 0.05, student t-test) between the average values, for any of 
the parameters listed, between lineages which have become extinct (A, B) and those 
which continue to circulate (C, D). There were no conserved polymorphic positions 
between extinct and circulating lineages. There were no conserved substitutions (e.g. 
A or T or G or C) that were exclusive to either extinct or circulating lineages. The 
most polymorphic sites were observed between nucleotides 500 to 1000 in both the 
extinct and circulating lineages, the frequency of these changes was not significantly 
different (p>0.69, Mann-Whitney test) between extinct and circulating lineages. A 
minority haplotype in extinct lineage M32514 and one in extinct lineage M36957 
contained stop codons in the ORF. However, no circulating lineages contained an 
intragenic stop codon. There were no insertions or deletions in the E genes of any 
lineages. 
To evaluate whether structural difference produced by non-conservative amino 
acid substitutions in the E gene had any influence on lineage extinction, the number 
and ratio of conservative and non-conservative changes were analysed between 
extinct and circulating lineages (Table 4.4). There was no significant difference (p> 
0.05, student t-test) in number and ratio of conservative and non-conservative 
changes between extinct and circulating lineages. There also was no domain bias in 
conservative and non-conservative changes between extinct and circulating lineages. 
Rather than identifying changes associated with lineage replacement it was 
remarkable how consistent the polymorphic sites were in all lineages, particularly 
those at E203 and E363/364. The changes at E203 took on additional significance in 
the following investigations. 
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Figure 4.13 Distribution of polymorphic sites in the E genes of haplotypes of 
DENV-1 Lineage A (M32514). Changes from the most prevalent haplotypes are 
shown as A: green, T: red, G: orange, C: light blue. The percentage of each 
haplotype in the population is shown in parenthesis. 
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Figure 4.14 Distribution of polymorphic sites in the E genes of haplotypes of DENV-1 Lineage B; (a) M31459, (b) M36957. Changes from the 
most prevalent haplotypes are shown as A: green, C: light blue. The percentage of each haplotype in the population is shown in parenthesis. 
  
(a) (b) 
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Figure 4.15 Distribution of polymorphic sites in the E genes of haplotypes of DENV-1 Lineage B; (c) M44988; (d) 47317. Changes from the 
most prevalent haplotypes are shown as A: green, C: light blue, G: orange. The percentage of each haplotype in the population is shown in 
parenthesis. 
  
(c) (d) 
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Figure 4.16 Distribution of polymorphic sites in the E genes of haplotypes of DENV-1 Lineage C; (a) M31987; (b) 47662. Changes from the 
most prevalent haplotypes are shown as A: green, G: orange, C: light blue. The percentage of each haplotype in the population is shown in 
parenthesis. 
  
(a) (b) 
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Figure 4.17 Distribution of polymorphic sites in the E genes of haplotypes of DENV-1 lineage C; (c) M49440, lineage D; (d) 68417. Changes 
from the most prevalent haplotypes are shown as A: green, G: orange, C: light blue. The percentage of each haplotype in the population is shown 
in parenthesis. 
  
(c) (d) 
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Table 4.3 Measures of intra-host genetic diversity among DENV-1 lineages. 
 
DENV-1 
lineage 
Name of 
the 
lineage 
Strain No. of 
haplotypes 
in E gene 
Proportion of 
haplotypes with 
consensus 
sequences 
Total number of 
variable sites 
Mean genetic diversity (%)
b
 
n.t a.a n.t a.a 
Extinct  A M32514
a
 6 90 42 6 0.03 0.03 
B M31459 3 95 2 1 0.005 0.01 
M36957
a
 6 47 5 5 0.02 0.02 
M44988 11 46 7 3 0.02 0.05 
M47317 5 94 4 3 0.005 0.01 
Survived C M31987 11 0 8 5 0.001 0.02 
M47662 7 81 5 3 0.001 0.01 
M49440 5 91 4 2 0.005 0.01 
D M68417 3 91 2 1 0.0002 0.01 
a
 one haplotype contain stop codon (one each). 
b 
Number of substitutions divided by the number of nucleotides/amino acids sequenced times 100. 
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Table 4.4 Conservative and non-conservative changes in E protein in haplotypes of 
DENV-1 lineages. Non conservative changes are shown in bold type. 
Lineage Strain Amino acid change 
(proportion in the population 
with the change) 
E gene 
domain 
A M32514 N8S (1%) I 
  N37D (1%) I 
  E203K (8%) II 
  D290E (3%) I 
  E362K (1%) III 
B M31459 V6I (100%) II 
  E203K (5%) II 
  P305S (100%) III 
  V320I (100%) III 
 M36957 V6I (100%) II 
  E203K (7.5%) II 
  P305S (100%) III 
  K363N (1%) III 
 M44988 E203K (7%) II 
  E203R (3%) II 
  K363N (1%) III 
  I398M (1%) III 
 M47317 E203K (4%) II 
  P305S (100%)  
  K363N (1%) III 
  P364Q (1%) III 
C M31987 G152E (0.3%) I 
  F193L (1.4%) II 
  E203K (2.4%) II 
  E203R (1%) II 
  K363N (1%) III 
  P364Q (1%) III 
 M47662 E203K (4%) II 
  K363N (0.1%) III 
  P364Q (0.1%) III 
  V480I (100%) III 
 M49440 E203K (2%) II 
  K363N (1%) III 
  V480I (100%) III 
D M68417 E203K (7%) II 
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4.6 EFFECTS OF INTER-HOST POPULATION BOTTLENECKS ON 
FITNESS OF DENV POPULATIONS 
The previous experiments provided no clear explanation as to why Myanmar 
DENV-1 lineage C has survived while lineages A and D have disappeared. Strains 
M68417 and M80579 (lineage D) were selected for further analysis to determine 
whether population bottlenecks might be sufficient to drive this newly arrived 
lineage to extinction. The distribution of fitness within these populations also 
differed (Figure 4.10) with approximately half of M68417 being more fit than the 
average for the population while in M80579, the proportions of the more fit, the 
average fit and the less fit were similar. 
 
The DENV-1 populations were passaged through five cycles of alternating 
mosquito (C6/36) and human (HuH7) cell cultures (total of 10 passages). Ten fold 
dilutions of these two DENV-1 populations were passaged at the same intervals in 
the same cells lines (Figure 4.18). The dilution chosen for the “bottleneck” passage 
was that which infected ~66 wells of a 96 well plate (Figure 3.2, Materials and 
Methods).  
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Figure 4.18 Protocol for alternate passage of DENV in mosquito (C6/36) and human 
(HuH7) cell lines. DENV were passaged either undiluted or diluted in both cell 
types. 
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Figure 4.19 presents the results of these experiments. The X axis indicates the 
cell line in which the virus was grown and the titres shown are the titres of the virus 
produced by these cells but with the infectivity determined in the alternate cell type 
i.e. the cells into which the virus was passaged in the next step in the experiment. 
Repeated passage of undiluted strain M68417 had little effect on the titre of virus 
produced as measured in the next cell type in the chain of infections. In contrast, 
DENV produced by C6/36 cells infected with the most dilute virus stocks had a titre 
of only 0.5 log10/ml in HuH7 cells and, despite repeated population bottlenecks 
thereafter, followed an erratic path of adaption such that after ten passages the m.o.i. 
had little effect on the infectivity of DENV produced in one cell type for the next. 
As with strain M68417, passage of undiluted stocks of strain M80579 through 
alternate mosquito (C6/36) and human (HuH7) cell lines resulted in little change in 
infectivity for the alternate cell lines. Passage of strain M80579 through repeated 
population bottlenecks resulted in similar dramatic changes in infectivity for 
alternate cell types as were seen with strain M68417. However, HuH7 cells appeared 
to be far more susceptible to infection with virus from the first bottleneck passage in 
C6/36 cells than did strain M68417. 
These experiments raised the question of whether the population bottleneck 
was due to an inability of DENV produced in one cell line to infect the second or 
whether it was due to decreased production of virus by infected cells. This has been 
addressed as follows. Populations of these two strains of DENV-1 were limit diluted 
to provide, a theoretical, one infectious dose of DENV to each well of a 96 well plate 
containing monolayers of either C6/36 or HuH7 cells. After 8 days, the culture 
supernatant from each well was transferred to a corresponding well of a new 96 well 
plate containing the alternate cell type i.e. from C6/36 to HuH7 cells or vice versa 
(Figure 4.20) and the cell monolayers stained for the presence of DENV E protein by 
ELISA. After a further 8 days, the fluid was removed from the second cell 
monolayers and they were stained for DENV E protein by ELISA. In all instances, 
cells, which were infected (stained for DENV E protein) produced sufficient virus to 
infect the alternate cell type (Table 4.5). 
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Figure 4.19 Titres of DENV-1 after alternate passage in C6/36 and HuH7 cells either 
diluted () or undiluted (). Initial 25 cm2 cultures of C6/36 cells were infected 
with 10
5.5
 C6/36 TCID DENV-1. (a) M68417 was passaged with undiluted and 
bottleneck in C6/36 and HuH7 alternatively. Titre of viruses was measured in 
alternate cells. (b) M80579 was passaged with a similar manner and the titres were 
measured in alternate cells. 
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Figure 4.20 Protocol for assessing the infectivity of DENV-1 produced by one cell type (C6/36 or Huh7 cells), infected with one infectious dose 
of virus for the alternate cell type. Blue wells indicate DENV-1 positive C6/36 or HuH7 cells and white wells indicate DENV-1 negative cells. 
DENV-1 appeared positive by cell ELISA in the two 96 well plates infected with the least diluted virus were selected. Supernatant from DENV-1 
positive wells were transferred into alternate cell type. 
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Table 4.5 Either C6/36 or HuH7 cells infected with approximately one infectious dose of 
DENV-1 produce sufficient virus to infect the other cell type. 
Strain Number of infected wells of 
C6/36 cells in 96 well plate 
No. of infected  wells 
after undiluted passages 
in alternate cells 10
-1
 10
-2
 
68417 86 10 86/86  10/10 
72 14 72/72 14/14 
80579 96 49 96/96 49/49 
71 3 71/71 3/3 
 Number of infected wells of 
HuH7 cells in 96 well plate 
  
 10
-1
 10
-2
 10
-3
 10
-4
   
68417   84 16 84/84 16 
 89 34  89/89 34/34 
80579 96 28   96/96 28/28 
  96 49 96/96 49/49 
 
 
Despite the repeated bottlenecks, these two DENV populations showed no evidence of 
a loss of fitness. To investigate any fitness tradeoffs that may have occurred during these five 
cycles of transmission in mosquito and human cells, samples recovered in the experiments 
shown in Figure 4.18 were titrated in both human and mosquito cells (Figure 4.21). A 
relatively consistent pattern was observed with the passage of undiluted stocks of strain 
M80579. After the initial infection in C6/36 cells, virus grown in human cells (HuH7) 
produced similar titres when assayed on C6/36 and HuH7 cells, while virus grown in 
mosquito cells (C6/36) produced higher titres when assayed in C6/36 than HuH7 cells. In 
contrast, it was not until the fourth passage in C6/36 cells that strain M68417 adopted this 
pattern. Up to this point, the virus produced in either C6/36 or HuH7 cells consistently 
produced higher titres when assayed on C6/36 cells. Similar comparisons were not made with 
the bottlenecked virus because of the extremely low titres of first passage M68417 virus in 
HuH7 cells (Figure 4.19). 
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Figure 4.21 Titres of undiluted passaged viruses measured either C6/36 () or HuH7 () 
cells. (a) M68417 was passaged alternatively in C6/36 and HuH7 without dilution. Titre of 
viruses produced from each cell types was measured in both C6/36 and HuH7. (b) M80579 
was passaged in a similar manner and the titres were measured in both cell types.   
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4.7 CHANGES IN NUCLEOTIDE AND AMINO ACID SEQUENCES DURING 
ALTERNATE PASSAGE OF DENV-1 IN MOSQUITO AND HUMAN CELLS  
The consensus nucleotide sequences of the genomes (nt 10-10170) of strains M68417 
and M80579 at various passages levels in C6/36 and HuH7 (Figure 4.19; 4.20) were 
determined by standard dye dideoxy chain termination sequencing (Sanger). Results are 
shown in Table 4.6. 
No nucleotide changes were detected in the consensus sequences of undiluted 
populations of strain M68417 after five alternating passages in C6/36 and HuH7 cells i.e. ten 
in vitro passages. Bottleneck passages of M68417 resulted in three unique nucleotide 
changes, two of which resulted in non-conservative amino acid changes. 
Six nucleotide changes resulting in two amino acid changes were detected in strain 
M80579 passaged undiluted. Four of these nucleotide changes had occurred by the second 
cycle of C6/36 - HuH7 transmission i.e. by passage 4. Bottleneck populations of M80579 had 
one unique nucleotide change at E608, which resulted in a non-conservative amino acid 
change E203K. This change was shared with the bottleneck population of M68417, i.e. the 
change was observed only in the bottleneck populations after five cycles of C6/36 – HuH7 
cell transmission. 
To investigate how quickly the mutation G608A occurred, the E gene was sequenced 
for all bottleneck passaged viruses. The mutation G608A was not observed in consensus 
sequences at any earlier passaged viruses. However, it was detected by the 454 sequencing in 
the E protein in minority populations (2-5%) of both parental viruses. 
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Table 4.6 Changes in the consensus nucleotide and amino acid sequences of DENV-1 following alternate passages in C6/36 and HuH7 cells. 
Sequences from passage 4 (P4) and 10 (P10) undiluted and bottleneck viruses were compared with those of the corresponding starting viruses. 
Similar changes in both strains of viruses are indicated in bold type. 
DENV 
Strain 
Gene Nt./a.a 
position in 
gene/protein 
Stock 
virus 
Undiluted 
(P4)  
Bottleneck 
(P4)  
Undiluted 
(P10)  
Bottleneck 
(P10)  
  nt aa nt aa nt aa nt aa nt aa nt aa 
M68417 Env 608 203 G E G E G E G E A K 
NS3 669  C R C R C R C R T R 
NS4B 126  T Y T Y T Y T Y C Y 
M80579 Capsid 231  G A G A G A T A T A 
PrM 40 13 C T T I T I T I T I 
 278  C V T V T V T V T V 
 309  C L T L T L T L T L 
 443  C I T I T I T I T I 
Env 608 203 G E G E G E G E A K 
NS4A 142  C T T T T T T E T T 
NS5 416 139 A K A K A K T N A K 
 418 140 T C T C T C A S T C 
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Chapter 5: DISCUSSION  
While nothing was found in the composition of populations of DENV-1 that 
might explain the clade replacements that have occurred in Myanmar over the last 
decade, in vitro experiments that attempted to mirror cycles of transmission between 
human and mosquito hosts in nature, resulted in identical changes in the E protein to 
that which had been observed in similar in vitro experiments with DENV-2 
(Vasilakis et al., 2009), albeit with some significant differences in how the genetic 
changes were generated.  
There is a growing body of literature suggesting RNA virus populations may 
strike a fine balance between having the necessary genetic diversity to survive in 
changing host environments by adapting to subtle, and not so subtle, changes 
(Vignuzzi et al., 2006) and the generation of so much diversity as to enter error 
catastrophe. While there is a body of data describing the nature and magnitude of 
genetic diversity in DENV populations (Aaskov et al., 2007; Aaskov et al., 2006; 
Craig et al., 2003; Li et al., 2011; Thai et al., 2012; Thu et al., 2005; Wang et al., 
2002b; Worobey et al., 1999; Zhang et al., 2006), this has suffered from two 
constraints imposed by the technology employed to obtain it. The first has been the 
amount of the genome that can be cloned into a single plasmid for subsequent 
sequencing and the second has been the logistics of sequencing large numbers of 
cloned genome fragments. Next-generation sequencing (NGS) has the, as yet 
unrealised, potential to address both these issues. While it has been relatively easy to 
generate enormous numbers of short sequences, assembling these into any significant 
lengths in any significant numbers remains a challenge. Nonetheless, an attempt was 
made to generate large numbers of DENV-1 E gene sequences from each of the 
populations chosen for this study. A cloned fragment of prM-E-NS1 was sequenced 
in parallel to provide an estimate of any sequence errors rising in NGS approach. 
DENV-1 infectious clone was sequenced as a control. It seems that the genetic 
diversity in DENV-1 populations was significantly greater (p>0.05, 1-sample t test) 
than just noise in this process. However, as the genetic diversity determined by 454 
sequencing was less than the previous estimates determined by cloning and 
sequencing (Aaskov et al., 2006; Chao et al., 2005; Craig et al., 2003; Thai et al., 
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2012; Wang et al., 2002b; Wittke et al., 2002). Similarly, the recent study 
(Parameswaran et al., 2012) also found that the nature and magnitude of intra-host 
genetic diversity in DENV-2 determined by 454 sequencing was significantly lower 
than previous estimates determined by cloning and sequencing (Aaskov et al., 2006; 
Chao et al., 2005; Craig et al., 2003; Wang et al., 2002b; Wittke et al., 2002). 
No association was observed between the nature and magnitude of the genetic 
diversity of the E genes of the DENV-1 chosen for study here and the extinction, or 
otherwise, of the lineage from which they were drawn. There were no lineage–
specific nucleotide substitutions or changes in the E gene of DENV that were likely 
to have contributed to the extinction of particular lineage viruses or have given a 
fitness advantage to all other lineages. Other studies (Thu et al., 2005; Wittke et al., 
2002) were also unable to detect any specific changes in the DENV genomes 
responsible for the lineage extinction.  
The nature and magnitude of the genetic diversity of the E genes determined by 
454 sequencing of the DENV in this study (Table 4.3) was 100 to 1000 fold less, 
than previously published DENV diversity (Aaskov et al., 2006; Chao et al., 2005; 
Craig et al., 2003; Wang et al., 2002b; Wittke et al., 2002). Mean nucleotide 
diversity estimated by cloning and sequencing was 2.3 – 0.1. However, the observed 
nucleotide diversity determined by 454 sequencing was 0.02 to 0.0002. Recent 
studies with lowest average levels of genetic diversity among all studies in DENV-1 
estimated in the E gene ranged from 0 to 0.0013 (Thai et al., 2012), which was still 
higher than the observed nucleotide diversity determined by 454 sequencing. The 
frequency of stop codons in our study determined by 454 sequencing, which were 
observed only in two samples, was less than 0.1%. However, the frequency of stop 
codons was reported to be 5.8% in the E gene by cloning and sequencing (Wang et 
al., 2002b).  
Twenty clones from strain M47317 contained 78 polymorphic sites and 1 stop 
codon while that from a similar number of clones of M49440 contained 89 
polymorphic sites and 11 stop codons (Aaskov et al., 2006). The same strains 
analysed by NGS in our study contained 4 (M47317) and 2 (M47440) polymorphic 
sites and no stop codons. However, these comparisons have been made employing 
cDNA generated from different stocks of virus using different primers. There is a 
need for comparisons to be made of diversity determined by NGS and by cloning and 
  
Chapter 4: DISCUSSION 99 
sequencing of the same cDNA and for all NGS reads to be included in analyses of 
SNPs rather than only those that can be assembled into complete E gene sequences. 
Roche 454 was chosen for this study over other NGS platform due to lower 
base substitutions and longer read which is easy to assemble (Liu et al., 2012). The 
fact that there was substantially less diversity generated in the 454 sequencing could 
be due to the selective amplification of sequences of a parental sub-population during 
RT-PCR to prepare cDNA and/or the selective assembly of contigs. It is possible that 
a lot of diversity is lost during the process of analysis because of the algorithms used 
to assemble the short reads generated from 454 sequencing and to reconstruct 
haplotypes of assembled sequences. However, fewer than 5% of sequence reads 
could not be assembled with the algorithms employed during the assembly process 
due to the parameters in algorithms used for assessing the reads for quality check 
(see Materials and Methods).  Nonetheless, it is possible that unassembled reads 
contained most of the diversity and that the algorithms did not assemble these 
sequence reads despite having them being true variants. Additionally, during 
analysis, the algorithms may consider singletons which are class of polymorphisms 
as errors, and subsequently correct the errors, despite some mutations may represent 
true biological variants (Thai et al., 2012).. 
Support for the possibility of selective assembly of contigs comes from the 
phylogenetic tree in Figure 4.11, in which the consensus sequence for M47317 lies 
between the branches of lineages C while all the sequences of the haplotypes lie with 
lineage B sequences. Close inspection of 5
/
 and 3
/
 end of the consensus sequence of 
E gene of M47317 revelled that the sequence have been derived from recombinant 
genome that fall into both lineages B and C (Figure 4.12).  
It also is possible that there was selective amplification of a sub-population(s) 
of M47317 genome in this study. The consensus sequence was obtained using 
oligonucleotide primers in the prM and NS1 genes adjacent to the 5
/
 and 3
/
 ends, 
respectively, of the E gene (Thu et al., 2005) while the sequences of the E genes in 
this study were derived from a larger prM-E-NS1 cDNA fragment generated with 
different in primers corresponding to Capsid and NS2A genes (see Materials and 
Methods).  
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Our hypothesis that accumulation of deleterious mutations led to the extinction 
of lineages was not supported by the data obtained for the frequency of indels and 
stop codons in the E gene. It is possible that critical changes occurred in other parts 
of these genomes that were responsible for the clade replacements and that the E 
gene was not a suitable surrogate for the measurement of these changes. However, 
there is a body of evidence (Parameswaran et al., 2012; Thu et al., 2005; Zhang et 
al., 2006) that the nature and magnitude of the diversity in E genes is similar to those 
in most other parts of the open reading frame. The other reason for choosing to study 
the E gene was that the largest amount of data relating to diversity in DENV has 
been obtained from the E gene and this would allow a more comprehensive 
comparison of the data from this study with that which has been published 
previously. Alternatively, changes in the sequence of the E protein, or other DENV 
proteins, could result in structural changes that altered virus replication but again, 
none of the amino acid changes that were exclusive to the extinct lineages occurred 
in regions of the E protein for with which critical functions have been assigned.  
Given the nature and magnitude of polymorphisms described in populations of 
DENV (Aaskov et al., 2007; Aaskov et al., 2006; Chao et al., 2005; Craig et al., 
2003; Holmes, 2003; Parameswaran et al., 2012; Thai et al., 2012; Wang et al., 
2002b; Wittke et al., 2002; Zhang et al., 2006), it seemed unlikely that the fitness of 
DENV populations in individual hosts would be simply the sum of the fitness of each 
individual. This seemed even less likely given the growing evidence that defective 
genomes of DENV can be complemented by other genomes that lack the defect in 
the first (Li et al., 2011). Despite the report that fewer than 5 per cent of members of 
populations of VSV were more fit than the population from which they were drawn 
(Duarte et al., 1994) and the observation that mixtures of populations of RRV 
containing less than 1% of a virulent strain but nonetheless displayed a virulent 
phenotype (Taylor & Marshall, 1975), there has been no attempt to quantify the 
distribution of fitness within populations of DENV and to compare these data with 
epidemiological patterns.  
This study found no association between the distribution of fitness of members 
with DENV-1 populations in mosquito cells and the survival or extinction of a 
lineage of viruses. However, there was an increase in the proportion of more fit 
members during and after the 2001-2002 outbreaks, suggesting that there may have 
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been some selection for DENV that grew to high titre in mosquitoes. This 
observation has two caveats. The first is that there was an increase in the proportion 
of more fit members in population 36957/00, compared to 31459/98 (clade B) before 
the outbreak began (36957/00 was recovered in the dengue season of 2000 in which 
the number of reported cases was low). The second is that the half life of an Aedes 
aegypti mosquito in Thailand (and presumably in neighbouring Myanmar) is only 7-
8 days (Harrington et al., 2001) and so selection might be for a virus that replicated 
faster rather than one that grew to high titre. However, DENV, which grows to high 
titre may also reach significant titres earlier.  
There also is a report of a DENV-1 lineage replacement that occurred in 
Thailand that may have been due to increased transmission of particular clades of 
virus by the mosquito hosts (Lambrechts et al., 2012). However, the authors 
employed strains of DENV-1 that had been passaged repeatedly in vitro, they 
measured only titres of virus in the mosquito hemocoel as a surrogate for actual 
transmission, there was no difference in the dissemination rates of the clades and 
only at 14 days post infection was there a difference (0.5 log10) between the two 
lineages in the titre of virus in the hemocoel. The average survival time of an Aedes 
mosquito in South-East Asia is only 7-8 days (Harrington et al., 2001), which is 
much shorter than the period required for the discrimination observed by Lambrechts 
et al.,(2012). Ty Hang and others (2010) reported that the Asian/American lineage of 
DENV-2 was replaced by the Asian 1 lineage in Vietnam due to the higher 
probability of human to mosquito transmission of the Asian/American lineage that 
produce a higher viraemia in the human host. However, they failed to determine 
whether the viruses that were measured in plasma samples were infectious, and 
whether there were any significant differences in infectivity among lineages in 
mosquitoes.   
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Central to this discussion is the definition of fitness. Some have chosen to 
define fitness as a measure of the ability to replicate (and produce infectious 
progeny) in a host (Domingo et al., 1999; Domingo & Holland, 1997) while more 
appropriate definition could be a measure of the ability to be transmitted, i.e. to infect 
the next host in a transmission cycle. While transmissibility is probably the most 
relevant measure for a virus like DENV with infection cycles involving alternate 
human and mosquito hosts, technical constraints prevented this measure being used. 
In this study, fitness was defined as the yield of DENV-1 virions from infected 
cells. 
An indirect ELISA procedure was employed to estimate the quantity of DENV 
virions released into culture supernatant (see Materials and Methods). It was 
accepted that a proportion of these would contain genomes that were not infectious. 
However, given the complexity of the interactions between RNA genomes e.g. 
complementation, interference by sub-genomic RNA etc., the yield of virions seemed 
to be a more relevant measure of productive infection than estimates of either the 
number of infectious virus particles (able to infect cell substrate) or of genome copy 
number. 
It was important to select appropriate human and mosquito cell lines for a 
suitable surrogate to measure fitness in vitro. The primary and/or major sites of 
DENV replication in humans are not known yet. Therefore, it was unclear what cells 
or cell lines might be appropriate substrates for experiments relevant to the human 
condition. A survey of the literature (Table 5.1) suggested DENV could be identified 
most commonly in the liver, as it was associated with liver dysfunction (Mohan et 
al., 2000; Nguyen et al., 1997; Wahid et al., 2000) and pathology (Bhamarapravati, 
1989; Bhamarapravati et al., 1967; Burke, 1968; Wahid et al., 2000) but it was not 
clear whether this was due to the extensive phogocytic activity of the liver 
(Couvelard et al., 1999; Huerre et al., 2001; Jessie et al., 2004; Ramos et al., 1998; 
Rosen et al., 1999; Rosen et al., 1989) or cells in the liver are more susceptible to 
infection than those in other tissues. However, in this study, all human cell lines 
including a number of liver cell lines were extremely refractory to infection by the 
low passage DENV-1 (Table 4.1). The use of HuH7 cells in this study reflected that 
these cells appeared to be the best available rather than that they were a productive 
cell substrate. Other investigators (Diamond et al., 2000) have struggled to find 
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human cell lines that are uniformly susceptible to infection by DENV from patient 
serum or by low passage DENV isolates.  
The fitness of populations of DENV was estimated by infecting two C6/36 cell 
monolayers in each 96 well plate with an undiluted stock of virus. Prior to 
undertaking these experiments, growth curves had been derived by infecting cultures 
of C6/36 cells with ten-fold dilutions of each of the DENV-1 populations. Because 
the growth curves were performed one virus strain at a time, it was not possible to 
make reliable comparisons of the titres of virus produced in each cell culture. With a 
number of these DENV populations (43826, 44988 [lineage B]; 47317 [lineage B]; 
47662, 49440, 62690 [lineage C] the highest titres of virus were produced with lower 
multiplicities of infection (Figure 4.4, Figure 4.5, Figure 4.6). This is suggestive of 
the presence of defective interfering viral particles (Li et al., 2011) and it was 
possible to demonstrate the presence of such genomes in these populations (Figure 
4.7). Many of the populations in which low m.o.i resulted in the highest titre virus 
also were those which had the largest proportion of “more fit” members suggesting 
that DI particles in the original undiluted, population may have been masking the 
fitness, which was revealed when the number of DI particles were reduced in the 
limit dilution for the fitness assays. Nonetheless, none of the changes observed 
appeared to correlate with survival or extinction of a clade of DENV-1.  
That individual members of DENV populations might vary in their fitness 
perhaps is not surprising given that there are reports of virions with genomes with 
mutations and indels giving rise to intragenic stop codons as well as genomes with 
deletions of thousands of nucleotides (Aaskov et al., 2006; Brinton, 1982; Cattaneo 
et al., 1988; Li et al., 2011; Noppornpanth et al., 2007; Pacini et al., 2009; Wang et 
al., 2002a; Wang et al., 2002b). There also is an extensive body of literature 
describing non-lethal changes that effect DENV replication (Clyde et al., 2006; 
García-Arriaza et al., 2007; Hsieh et al., 2011; Lambrechts et al., 2012; Lin et al., 
2011; Ty Hang et al., 2010). 
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Table 5.1 Detection of DENV in autopsy tissues of human. 
Authors Tissues/cells involved 
for DENV infection 
Techniques used for 
identification 
Comments 
(Jessie et al., 2004) Liver, spleen, lung, 
kidney, bone marrow 
and blood-clot samples 
Immunohistochemistry 
and in situ hybridization 
Highest proportion of positive cells was found in spleen. 
Although they were able to detect viral antigen, they were 
not certain of the location where viral RNA localized. 
(Huerre et al., 2001) Liver, blood Immunohistochemistry 
and RT-PCR 
Clear demonstration of DENV localization in hepatocytes 
and Kupffer cells.  
(Couvelard et al., 
1999) 
Hepatocytes in liver Immunohistochemistry 
and histopathology 
Could not detect DENV antigen in spleen, lungs, heart, 
kidney, adrenals, intestinal tract, pancreas. 
(Rosen et al., 1999) Liver, spleen and 
mesenteric lymph node 
RT-PCR Virus was only isolated from liver. 
Could not detect DENV RNA in brain and kidney. 
(Ramos et al., 1998) Brain Immunohistochemistry 
and RT-PCR 
Could not detect DENV antigen in other tissues.  
(Kangwanpong et 
al., 1995) 
Liver, macrophages in 
skin and lymph nodes 
In situ PCR and DNA 
hybridization 
Could not detect DENV antigen in other tissues. 
 
(Rosen et al., 1989) Liver, spleen, midbrain 
and heart blood 
Mosquito inoculation and 
immunoflurescence 
Most DENV antigen in the liver. 
(Nisalak et al., 1970) Lymph node and bone 
marrow 
Suckling mice and 
African green monkey 
kidney cells 
Could not detect DENV antigen in liver, spleen, lungs, 
heart, kidney, adrenals, intestinal tract, pancreas and brain 
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A comparison of titres of DENV in patients measured as infectious virus or as 
genome copy number suggested that copy number values are 10-100 times higher 
than infectious titres (Houng et al., 2001; Ty Hang et al., 2010; Vaughn et al., 2000). 
Taken together with the comments above, it seems unlikely that an individual cell is 
infected by a single DENV genome. For these reasons, a unit, “one infectious dose” 
has been used in this study and has been derived statistically, i.e. if 96 infectious 
units of virus in 9.6 ml are aliquoted uniformly into 96 wells of a microtitre plate, 
only 65 wells will contain virus (some wells will contain more than one infectious 
dose). While this is a weakness of this approach, there was no alternative, and the 
same methodology was used for all populations, so enabling comparisons to be 
made.  
These investigations focussed on DENV infections in C6/36 mosquito cells and 
more informative changes may have been revealed if similar studies were undertaken 
in human cells. However, it was not possible to identify a human cell line that was 
sufficiently susceptible to infection with all low passage strains of DENV (Table 
4.2). Furthermore, the most susceptible human cell line, HuH7, required a FBS 
supplement for growth and the FBS reduced the sensitivity of the ELISA employed 
to quantitate DENV in culture supernatants. 
As there appeared to be no explanation for DENV-1 lineage replacement in the 
composition of the Myanmar DENV-1 populations, experiments were undertaken to 
determine the effect of population bottlenecks, such as might occur during 
transmission between hosts, on the fitness of these populations. A population 
bottleneck has been defined as the transfer of only a small number of members 
of a viral population between hosts. Both theoretical and experimental studies with 
RNA viruses suggest that repeated population bottlenecks select virus populations 
that are less fit than the population from which they were derived (Chao, 1990; 
Clarke et al., 1993; Duarte et al., 1992; Escarmís et al., 1996; Yuste et al., 1999) due 
to the Muller’s ratchet (Muller, 1964) effect. Recent studies have demonstrated the 
bottleneck events that resulted in a significant drop in genetic diversity in 
arboviruses, e.g. in VEEV (Forrester et al., 2012) and in WNV (Ciota et al., 2012). 
However, the potential effects on fitness which ultimately impacted on arbovirus 
transmission have not been evaluated.  
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Loss of fitness was not observed in DENV-1 populations (Figure 4.19) 
recovered from alternate bottleneck passages in mosquito (C6/36) and human 
(HuH7) cell cultures. In fact, both strains of virus adapted to growth in HuH7 cells, 
albeit at different rates (Figure 4.19). The strain M68417 appeared to be highly 
adaptable in C6/36 cells (Figure 4.19), and had more members of more fit than the 
population as a whole in C6/36 cells (Figure 4.10). This may have slowed adaptation 
in the alternate cell type, HuH7. DENV population M80579 appeared to be less 
adaptable in C6/36 cells (Figure 4.19), which may have been due to a different mix 
of members which are more, or less fit than the population as a whole (Figure 4.10).  
Bottleneck passage of these DENV-1 populations resulted in enrichment of a 
minor sub-population with a Glu-Lys substitution at E203 (Table 4.6). The fact that 
this mutation appeared in consensus sequences from minority sequences (2-5%) after 
ten alternative passages in DENV, suggested the mutation appeared may be due to 
some sort of selective advantages during replication. It is possible that the Glu-Lys 
substitution at E203 may have enhanced the affinity of DENV for GAG on the cell 
surface. A substitution for Lysine from Glutamic acid at E202 in DENV-2 resulted in 
greater GAG-mediated binding to host cells (Lee et al., 2006). Additional 
investigations are needed to confirm whether Lys substitution at E203 in DENV-1 
resulted GAG-mediated infection of host cells.  
In the crystal structure, the site of the substitution at E203 is not exposed on the 
native E protein dimer (Figure 5.1a) and so was unlikely to interfere with binding to 
host cell receptors or to influence monomer-monomer interactions. Following the 
low pH-induced conformational changes that precede fusion of an E protein trimer 
with host cell membranes (Modis et al., 2004; Zhang et al., 2004), the E 203 site is 
exposed (Figure 5.1b) but not in a position that has any obvious influence on the 
fusion process. Further investigations are needed to determine whether the DENV 
with a Glu-Lys substitution at E203 result any conformational change during 
replication.  
The substitution, Glu-Lys at E203, in amino acid properties in the DENV E 
protein dimer caused an increase in the net positive charge (negative to positive). 
Although the functional significance of the change from glutamic acid to lysine in 
the E protein is not known, several studies identified the same change, suggesting the 
change could be responsible for cell specific adaptation. The same change, E203 
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Glu-Lys, also was observed in the E protein of DENV-2 after alternate passages in 
C6/36 and HuH7 cells (Vasilakis et al., 2009) and in TBE when passaged in BHK-21 
cells (Mandl et al., 2001). Recombinant TBE virus with E201 Lys showed higher 
efficiency of binding to BHK-21 cells. Several studies with flaviviruses have shown 
amino acid substitutions in the E protein that result in charge changes could affect 
mouse neurovirulence (Chen et al., 1995; Jennings et al., 1994; Sumiyoshi et al., 
1995). Such non-conservative amino acid substitutions that resulted the change in 
charge are perhaps more likely to induce structural changes in the E protein that 
could affect function. 
 
 
Figure 5.1 The mutation, E203K is indicating in circles in DENV envelope protein 
dimer (a) and in envelope protein fusion complex (b) inside in infected cell.  
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Failure of the populations to undergo fitness loss may have been due to the 
insufficient “less fit” members of the populations for a stochastic event to result in 
selection of less fit variants or to the strong selective sweeps removing defective or 
less fit variants during replication in each cell type. Other possible explanation could 
be that the population bottlenecks we created were not tight enough to have an effect 
on fitness. Although, less than 50 infectious doses (IDs) (Figure 3.1) for each 
passage in ~10
6
 cells (~0.00005 m.o.i) were used, fitness did not decrease.  
The minimum amount of DENV required to infect natural mosquitoes varied 
between log10 
6.7-8.3
 MID50/ml (titres in feeding blood meal suspension) (Gubler et 
al., 1979). The amount was more than the dose that we used in each alternating 
passage. The minimum amount of DENV required to infect in human is not known. 
The mosquitoes can transmit as much as 10
3-5
 MID50/ml DENV that present in 
saliva (Gubler & Rosen, 1976), which also were more than the dose that we used in 
each passage. Therefore, functional bottleneck for DENV could not be possible in 
nature during transmission with such a high dose required to infect in mosquitoes and 
humans. 
Another possible hypothesis could be that the size of the functional bottleneck 
is too small that could not be detected with our existing methods. The functional 
bottleneck could be less than what we can create artificially and this bottleneck size 
is below the level of detection. While the genome copy number values are 10-100 
times higher than infectious titres (Houng et al., 2001; Ty Hang et al., 2010; Vaughn 
et al., 2000), it is unlikely that an individual cell is infected by a single DENV 
genome. Although we created a single infectious dose in 96 well plates, that dose 
could consist of a number of infectious and defective virion, which may have 
prevented the bottleneck effects. However, at this moment we are unable to 
quantitate the number of virions in a single infectious dose of DENV with our 
existing tools. Therefore, it may not be possible to measure the effects of the 
population bottlenecks of DENV. 
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Although the potential for repeated population bottlenecks should restrict 
genetic diversity and cause a decline in fitness due to Muller’s ratchet (Muller, 1964) 
effect, our results (Figure 4.19) were in contrast with those of other single host RNA 
viruses (Chao, 1990; Domingo et al., 2005; Duarte et al., 1992; Elena et al., 1996; 
Elena et al., 2001; Escarmís et al., 1996; EscarmIs et al., 1999; Escarmis et al., 2008; 
Yuste et al., 2000; Yuste et al., 1999) and, in particular, arboviruses (Ciota et al., 
2012; Forrester et al., 2012). However, while non-consensus minority populations 
were shared among samples collected from naturally infected birds, which is 
suggesting they are not subject to bottlenecks during natural transmission cycles 
(Jerzak et al., 2005). Additionally, virus populations, particularly DENV-1, may 
have the ability to overcome the effects of bottlenecks during natural transmission 
cycles because of defective genomes that persist through the complementation of 
functional genomes co-infection in cells in both mosquitoes and humans (Aaskov et 
al., 2006). The author suggested that the inter-host bottleneck during DENV 
transmission may be quite wide and allows a large and diverse population to pass 
from one host to vector and vice versa.  
Even though there is a possibility of intra-host bottleneck during initial midgut 
infection in mosquitoes due to the limited oral susceptibility (Kenney et al., 2012; 
Scholle et al., 2004; Smith et al., 2008), recent studies have demonstrated that WNV 
diversity is maintained throughout mosquito infection without showing any 
anatomical bottlenecks (Brackney et al., 2011), suggested bottlenecks may be 
compensated by further viral replication and recovery of diversity within mosquitoes. 
Our results also do not support the “trade-off” hypothesis that host alternation 
necessitates a fitness “trade-off”. While DENVs have to maintain alternative 
replication cycles in mosquito and human hosts to survive in nature, alternative 
transmission cycles often constrain virus evolution because of different selective 
pressures imposed on viruses during replication. This phenomenon is often called a 
“trade-off” because when fitness increases in one host it usually diminishes fitness in 
another host. Studies with DENV showed that alternate passaging facilitates 
adaptation in cell cultures (Vasilakis et al., 2009), which supports our results that 
alternate passaging resulted in adaptation in cells, particularly in HuH7 cells (Figure 
4.19, Figure 4.21). Other studies (Coffey & Vignuzzi, 2011; Cooper & Scott, 2001; 
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Greene et al., 2005; Weaver et al., 1999) also argued against that arboviruses require 
trade-offs for host cycling (Table 2.2). 
This study has provided clear evidence that the lineage turnover in DENV 
transmission is not due to any selective pressures because of the variation in fitness 
within populations, or any role of genetic diversity or the random sampling of viral 
variants during inter-host population bottleneck. As Myanmar is a hyperendemic 
country, the presence of multiple DENV serotypes may result in complex patterns of 
cross-immunity, which might determine which clades survive and which become 
extinct (Thu et al., 2005; Thu et al., 2004). This study has provided indications that 
the process of lineage extinction and replacement events may be due to the stochastic 
nature of DENV evolution during transmission. It is possible that when multiple 
lineages of DENV-1 are co-circulating in a particular area, certain lineages may be 
outcompeted randomly (Clarke et al., 1994) during direct competition between them. 
Alternatively, some random events may be associated with low rates of virus 
transmission during the inter-epidemic interval, resulting in extinction of lineage 
viruses. Similar rapid extinctions and appearances of new lineages of DENV-2 and 3 
were also observed during inter-epidemic periods in Thailand (Sittisombut et al., 
1997; Wittke et al., 2002). It is also possible that the extinction of lineages that 
occurs in DENV populations may be due to the seasonal (dry seasonal and monsoon) 
variations in the size of the mosquito vector populations. These dramatic changes in 
the genetic structure of DENV populations result in significant changes in disease 
patterns and indicate that ecological factors may play an important role in DENV 
evolution. 
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Replacements of DENV clades often precede major outbreaks of disease (Thu 
et al., 2004; Wittke et al., 2002) and so have significant health, social and financial 
consequences. It seemed more likely that clade replacements resulted from more 
efficient replication of “new” strains than due to direct competition between strains 
within individual hosts. For this reason, explanations for clade replacement were 
sought in the composition of individual populations of “winning” and “losing” clades 
of DENV 1 recovered around a major clade replacement and dengue outbreak in 
Myanmar in 2001-2002. 
While there were no significant correlations between accumulation of 
deleterious mutations or increasing genetic diversity and clade extinction, this issue 
has not been resolved because of the major differences in these parameters when 
measured by next generation sequencing and traditional cloning and sequencing. 
As has been observed with VSV (Duarte et al., 1994) most members of most 
DENV 1 populations were less fit than the population from which they were drawn. 
This would seem to point to extensive complementation between the 90-99 per cent 
of dengue genomes that are not capable of replicating by themselves (Houng et al., 
2001; Ty Hang et al., 2010; Vaughn et al., 2000) as well as to complex fitness 
outcomes depending on the size of the population initiating an infection. However, 
an increase in the proportion of “more fit” members of a DENV population did not 
appear to be sufficient to guarantee survival of a lineage. 
There were two lines of evidence which suggested that population bottlenecks 
in the transmission cycles of DENV rarely are stringent enough to lead to extinction 
of a lineage. The in vivo evidence was that, despite repeated bottlenecks in nature, 
over time periods of several years, the proportion of more fit members in DENV 
populations appeared to increase. The in vitro evidence, from repeated passage of 
DENV in alternating human and mosquito cells, suggested that the fitness of DENV-
1 for growth in human cells increased following population bottlenecks. 
  
 112 Chapter 6: CONCLUSIONS 
The explanation for clade replacement may lie with the phenotype of the host 
with the more susceptible hosts (host proteins able to support the replication of 
DENV most efficiently; the innate immune system least able to resist infection) 
being infected more readily after appearance of a new clade such that, after several 
years, the virus struggles to survive. A new clade, with a different phenotype, may be 
able to exploit hosts which the resident clade is struggling to infect. 
This study has extended our understanding of the complexity of DENV 
populations and of interactions between members of individual populations. It also 
has highlighted significant technical issues to be resolved in the way the diversity of 
DENV, and other viral, populations is measured.  
A greater understanding of the population dynamics of DENVs may lead to 
more effective public health interventions to control dengue, particularly 
immunization strategies. This takes on added significance with the disappointing 
results from the recent dengue vaccine trial in Thailand (Sabchareon et al., 2012).  
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6.1 FUTURE DIRECTIONS  
The results of this study demand some further investigations to enhance our 
understanding on the evolution of DENV, which are as follows 
1. Determine the effect of the G608A change in the E gene of a DENV-1 
infectious clone-derived virus (in vitro and in mosquitoes).  
2. Quantitate changes in the distribution of fitness within populations of DENV 
that accompany the fluctuations in population fitness during alternate passage 
in mosquito and human cells in vitro. 
3. Investigate the nature and magnitude of the nucleotide/amino acid changes 
that accompanied the fluctuations in fitness of DENV populations during 
alternate passage in mosquito and human cells in vitro. 
4. Compare the fitness of DENV in individual mosquitoes and patients (i.e. 
unpassaged) in human and mosquito cells in vitro. 
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Appendices  
Appendix A 
 
Conferences and seminar 
•Presented a paper entitled “Fitness within populations of DENV and lineage 
replacement” at the Australian Arbovirus Symposium, Gold Coast, September, 2012.  
•Presented a seminar entitled “Population fitness of dengue viruses” at the Arbovirus 
Laboratory, New York State Department of Health, USA, 2012. 
•Co-author on a presentation entitled “For what is a dengue virus fit” at the American 
Society of Tropical Medicine and Hygiene 59th Annual Meeting, USA, 2010. 
•Presented a paper entitled “Distribution of Fitness in Population of Mosquito Borne 
RNA Viruses” at the IHBI Inspires Conference 2010, Gold Coast. 
 
Meetings and workshops 
 
•Attended IGS Genomic workshop, 2012 in Institute for Genome Science, University 
of Maryland, USA. 
•Attended in workshops for Endnote, SPSS software and Thesis writing using word 
2007 and EndNote. 
•Attended Statistical symposia.  
•Participated an Introduction to Scanning Electron Microscope at QUT. 
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Appendix B 
Web address of raw data for 454 sequence analysis.  
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID1_31459.fna 
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID2_31987.fna 
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID3_32514.fna 
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID4_36957.fna 
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID5_43826.fna 
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID6_44988.fna 
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID7_47317.fna 
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID8_47662.fna 
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID9_49440.fna  
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID10 62690.fna 
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID10_62690.fn
a 
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID11_68417.fn
a 
https://fileshare.qut.edu.au/public/choudhum/1.GAC.454Reads_RLMID12_80579.fn
a 
Web address for 454 sequence coverage 
 
https://fileshare.qut.edu.au/public/choudhum/31459.pdf 
https://fileshare.qut.edu.au/public/choudhum/31987.pdf 
https://fileshare.qut.edu.au/public/choudhum/32514.pdf 
https://fileshare.qut.edu.au/public/choudhum/36957.pdf 
https://fileshare.qut.edu.au/public/choudhum/43826.pdf 
https://fileshare.qut.edu.au/public/choudhum/44988.pdf 
https://fileshare.qut.edu.au/public/choudhum/47317.pdf 
https://fileshare.qut.edu.au/public/choudhum/47662.pdf 
https://fileshare.qut.edu.au/public/choudhum/49440.pdf 
https://fileshare.qut.edu.au/public/choudhum/62690.pdf 
https://fileshare.qut.edu.au/public/choudhum/68417.pdf 
https://fileshare.qut.edu.au/public/choudhum/80579.pdf 
https://fileshare.qut.edu.au/public/choudhum/Infectious_Clone.pdf 
 
Web address of SNPs and haplotypes for 454 sequence analysis 
 
https://fileshare.qut.edu.au/public/choudhum/RESULTS_Egene.zip 
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Sequence alignment 
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